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ABSTRACT OF THE DISSERTATION
ASSESSMENT OF THE OCCURRENCE AND POTENTIAL RISKS OF
PHARMACEUTICALS AND THEIR METABOLITES IN FISH AND WATER
USING LIQUID CHROMATOGRAPHY MASS SPECTROMETRY
by
Jian Wang
Florida International University, 2013
Miami, Florida
Professor Piero Gardinali, Major Professor
A comprehensive method for the analysis of 11 target pharmaceuticals
representing multiple therapeutic classes was developed for biological tissues
(fish) and water. Water samples were extracted using solid phase extraction
(SPE), while fish tissue homogenates were extracted using accelerated solvent
extraction (ASE) followed by mixed-mode cation exchange SPE cleanup and
analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS).
Among the 11 target pharmaceuticals analyzed, trimethoprim, caffeine,
sulfamethoxazole, diphenhydramine, diltiazem, carbamazepine, erythromycin
and fluoxetine were consistently detected in reclaimed water. On the other hand,
caffeine, diphenhydramine and carbamazepine were consistently detected in fish
and surface water samples.
In order to understand the uptake and depuration of pharmaceuticals as well as
bioconcentration factors (BCFs) under the worst-case conditions, mosquito fish
were exposed to reclaimed water under static-renewal for 7 days, followed by a
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14-day depuration phase in clean water. Characterization of the exposure media
revealed the presence of 26 pharmaceuticals while 5 pharmaceuticals including
caffeine, diphenhydramine, diltiazem, carbamazepine, and ibuprofen were
present in the organisms as early as 5 h from the start of the exposure.
Liquid chromatography ultra-high resolution Orbitrap mass spectrometry was
explored as a tool to identify and quantify phase II pharmaceutical metabolites in
reclaimed water. The resulting data confirmed the presence of acetylsulfamethoxazole and sulfamethoxazole glucuronide in reclaimed water. To my
knowledge, this is the first known report of sulfamethoxazole glucuronide
surviving intact through wastewater treatment plants and occurring in
environmental water samples.
Finally, five bioaccumulative pharmaceuticals including caffeine, carbamazepine,
diltiazem, diphenhydramine and ibuprofen detected in reclaimed water were
investigated regarding the acute and chronic risks to aquatic organisms. The
results indicated a low potential risk of carbamazepine even under the worst case
exposure scenario. Given the dilution factors that affect environmental releases,
the risk of exposure to carbamazepine will be even more reduced.
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CHAPTER 1
Introduction

1

1.1 Occurrence of pharmaceutically active compounds in the environment
Pharmaceutically active compounds are now well-acknowledged environmental
pollutants. They are released into the environment largely through the discharge
of wastewater treatment plants (WWTPs) as a result of excretion and metabolism
by humans and animals, and additionally, disposal of unused or expired drugs
(Daughton and Ternes 1999; Miao and Metcalfe 2003; Vanderford et al. 2003).
However, most WWTPs are not specifically designed to remove most of the
pharmaceuticals, thus these compounds are present in reclaimed and surface
waters in a wide range of concentrations (Heberer 2002; Boyd et al. 2003).
Besides parent pharmaceuticals, the presence of pharmaceutically active
compounds in the environment can also be in the form of transformation products
(i.e. 10,11-dihydro-10,11-dihydroxycarbamazepine, the major metabolite of
carbamazepine, and norfluoxetine, the major metabolite of fluoxetine) (Miao and
Metcalfe 2003; Brooks et al. 2005; Miao et al. 2005; Chu and Metcalfe 2007).
Parent drugs can be excreted as the unchanged form (Miao et al. 2005) whereas
transformation products can be formed as metabolites by undergoing chemical or
biochemical transformation (Gobel et al. 2004) or as photodegradation products
by exposure to sunlight (Bonvin et al. 2012). Current research is heavily focusing
on unchanged parent drugs (Celiz et al. 2009). However, it is important to realize
that the exposure to metabolites may have hazardous effects similar to those of
the parent drugs (Bedner and MacCrehan 2006).
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1.2 Adverse effects under chronic exposure
Although concentrations in environmental water bodies are typically at ng/L to
low µg/L level, these organic pollutants may still pose risks to aquatic species
under chronic long-term exposure (Vanderford et al. 2003; Brooks et al. 2005;
Owen et al. 2007; Gunnarsson et al. 2008). For instance, after a 21-day
exposure, fluoxetine was shown to induce vitellogenin in male fathead minnows
(Pimephales promelas) at 28 ng/L and venlafaxine caused mortality of fathead
minnows at concentration as low as 305 ng/L (Schultz et al. 2011). Similarly,
plasma samples from the rainbow trout (Oncorhynchus mykiss) exposed to
sewage effluents were analyzed for 25 pharmaceuticals, of which levonorgestrel
was detected in fish plasma at concentrations (8.5-12 ng/mL) exceeding the
human therapeutic plasma level (Fick et al. 2010). Because many aquatic
species were shown to have similar physiological receptors to those the
pharmaceuticals are originally intended to react with in humans (Gunnarsson et
al. 2008; Quinn et al. 2009), the data suggested a high risk of pharmacological
effects on rainbow trout (Fick et al. 2010).
Another study concerning the uptake and depuration as well as bioconcentration
factors

(BCFs)

of

pharmaceuticals

including

moclobemide,

5-fluoruracil,

carbamazepine, diazepam, carvedilol and fluoxetine was conducted in freshwater
shrimp (Gammarus pulex) and water boatman (Notonecta glauca) after a 2-day
uptake phase (Meredith-Williams et al. 2012). The results showed that BCFs in
freshwater shrimp were significantly higher than those found in water boatman,
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implying that pharmaceuticals may possess even higher risks to smaller aquatic
species as environmental pollutants.
1.3 Reclaimed water exposure
A freshwater pond located at Florida International University Biscayne Bay
Campus (North Miami Beach, FL) continuously receives storm water runoff and
reclaimed water from a local WWTP through daily sprinkler irrigation. The source
of reclaimed water was Miami-Dade Water and Sewer Department North District
Wastewater Treatment Plant. Pure oxygen activated-sludge was used in the
WWTP as the main secondary treatment process. Extra filtration and disinfection
were applied to effluents before release to make the reclaimed water ready for
use in irrigation. Fish are sensitive indicators for the substances that enter
aquatic ecosystems (EPA 2009). Therefore, the aquatic organisms living in this
pond are likely to be chronically exposed to the contaminants from reclaimed
water. It is also expected that aquatic systems like this freshwater pond
influenced by substantial inputs of reclaimed water may represent a good model
to study the exposure of biological resources to mixtures of pharmaceuticals
under relatively natural conditions (Brooks et al. 2006).
1.4 Current analytical protocols of detecting pharmaceuticals in water and
biological samples
On the basis of the complexity of environment matrices and the multiple
functionalities of emerging contaminants as target compounds, recently
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described analytical protocols for the determination of pharmaceuticals in both
wastewaters (Segura 2007; Lajeunesse et al. 2008; Segura 2009) and biological
organisms (Tavazzi et al. 2002; Brooks et al. 2005; Chu and Metcalfe 2007;
Berrada et al. 2008) have focused on rather specific classes of compounds.
Antidepressants (Brooks et al. 2005; Chu and Metcalfe 2007; Lajeunesse et al.
2008) and antibiotics (Segura 2007; Berrada et al. 2008; Segura 2009) are the
two classes that have been studied the most. As the list of compounds found in
field collected fish samples expands, the need to develop simultaneous
screening methods for multiple classes of drug residues increases as well
(Balmer et al. 2004; Duedahl-Olesen et al. 2005; Buser et al. 2006; Rudel et al.
2006; Mottaleb et al. 2009). At present, the general approach employed for the
analysis

of

multi-class

pharmaceuticals

in

fish

involves

extraction

of

homogenized tissue with 1:1 mixture of 0.1 M acetic acid and methanol (Ramirez
et al. 2007), or acetonitrile combined with limited cleanup to back-extract lipid
material followed by liquid chromatography-mass spectrometry (LC-MS) analysis
(Smith et al. 2009). Additionally, the use of solid-phase microextraction (SPME)
techniques has also been explored as surrogates to estimate the potential
occurrence and uptake of pharmaceuticals in living fish by assuming similar
partition behavior between the SPME devices and the fish tissues placed in
contaminated environments (Zhou et al. 2008).
Accelerated solvent extraction (ASE) involving high pressure and temperature
has been shown to efficiently extract a wide range of compounds from fish

5

tissues (Draisci et al. 1998; Datta et al. 2002; Tavazzi et al. 2002; Wahlen 2004;
Chu and Metcalfe 2007; Haglund et al. 2007; Berrada et al. 2008; Llorca et al.
2009; Losada et al. 2009; Lund et al. 2009). Meanwhile, HLB polymeric
cartridges are routinely used as SPE sorbent for cleanup of complex
environmental samples prior to LC-MS analysis. However, on the basis of
considerable variation in lipophilicity and pKa among different classes of
pharmaceuticals, optimum cleanup efficiency can be compromised by differential
retention behavior of target analytes on the sorbent. In contrast, mixed-mode
cation exchange (MCX) cartridges can accommodate both neutrals and cations
providing better selectivity during elution steps. For instance, Chu et al. (Chu and
Metcalfe 2007) developed a method to determine paroxetine, fluoxetine and its
metabolite in fish tissue using accelerated solvent extraction followed by MCX
cleanup offering better recoveries and minimized matrix interferences. Because
of the capabilities mentioned above, mixed-mode MCX cartridges will likely
provide the needed retention for the multiple classes of pharmaceuticals
proposed herein.
1.5 Why is it needed to improve the throughput of current on-line SPE
methods for pharmaceutical analysis?
As the list of pharmaceutically active compounds being reported in various
environmental matrices keeps growing, it is of obvious importance to develop
new analytical techniques that are more effective at analyzing multiple
components in a large number of samples in limited time (Balmer et al. 2004;
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Buser et al. 2006; Mottaleb et al. 2009). In order to address the needs for lower
detection limits and higher sample throughput, an on-line SPE coupled to mass
spectrometry detection was developed to eliminate several preparation steps
such as evaporation and reconstitution (Segura 2007; Garcia et al. 2009; Wang
and Gardinali 2012). More recently, on-line SPE LC-MS/MS has become a more
desired technique in routine analysis of aqueous samples, especially for the
samples that are time sensitive and need large injection volume to improve
sensitivity.
The time for a typical on-line SPE LC-MS/MS analysis consists of autosampler
preparation time, sample withdraw time, SPE loading and elution time, and
separation time. On the basis of the fact that loading speed is at 1 mL/min, total
run times could be quite long when large sample volume (i.e. 20-50 mL) is used
to improve detection limits. To shorten the time between injections, “look ahead”
mode can be enabled so that the autosampler sets up for the next injection
during the current run. Although the “look ahead” mode can be used to
incorporate

autosampler

preparation

and

sample

withdraw

time

into

chromatography time, the sample is still aspired into the sample loop during the
next run cycle. In addition, the dead volume of large sample loops (>5 ml)
creates a massive delay of gradient changes and increases the uncertainty of
mobile phase mixing.
In the present study, default autosampler program commands were modified
from 1-draw sample, 2-move to injection port, 3-aspire sample, 4-inject and 5-
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washing to 1-inject, 2-wait, 3-switch injection valve to load, 4-washing, 5-draw
sample, 6-move to injection port, and 7-aspire sample. The amount of time that
the modified autosampler program took was compared with those needed for the
default injection mode and “look ahead” mode. Efficiencies for the washing steps
of injection syringe and sample loop which lead to carryover were also
investigated among the default autosampler program, look ahead, and the
modified autosampler program for all the compounds in laboratory routine
analysis of water samples.
1.6 Why is pharmacokinetics under the “worst case scenario” important?
First of all, pharmacokinetic data describing the uptake and depuration of
pharmaceuticals by aquatic species are extremely limited compared to those in
mammals (Paterson and Metcalfe 2008; Meredith-Williams et al. 2012), thus it is
important to study the uptake and depuration rates in systems that may represent
“worst case exposure” without compromising the environmental relevance (Fick
et al. 2010). Most aquatic monitoring studies designed to simulate exposure
under environmentally relevant concentrations were performed in artificially clean
matrices (Nakamura et al. 2008; Paterson and Metcalfe 2008; Hoang et al. 2011;
Meredith-Williams et al. 2012), often with exposure concentrations still higher
than those would be found under natural conditions by one or more orders of
magnitude (Paterson and Metcalfe 2008; Hoang et al. 2011). Although this
approach maximizes the chances of quantifying any compounds that might
accumulate with confidence, results are often not in good agreement with those
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from the field (Nakamura et al. 2008; Paterson and Metcalfe 2008; MeredithWilliams et al. 2012). Reclaimed water produced by conventional primary and
secondary treatment offers good surrogacy for a worst case exposure scenario
and could be used to predict the extent of bioconcentration and toxicological
thresholds in aquatic organisms without resourcing to unrealistic concentrations
(Paterson and Metcalfe 2008).
1.7 Identification of pharmaceutical metabolites in reclaimed water
Numerous analytical instruments have been applied to investigate the
occurrence of parent drugs in a variety of environmental matrices (Vanderford et
al. 2003; Davis et al. 2006; Kwon and Armbrust 2006; Ramirez et al. 2007;
Schultz et al. 2010; Wang and Gardinali 2012). In contrast, little attention has
been paid to the identification, let alone quantification, of pharmaceutical
metabolites (Celiz et al. 2009) because there could be numerous metabolites
from one parent drug and it is also practically impossible to purchase or
synthesize standards for all the metabolites, not to mention the economical
unsoundness. As a result, current targeted analysis of metabolites using tandem
mass spectrometry is only limited to pharmaceuticals whose metabolites are well
studied from clinical data and standards for the metabolites are readily available
to purchase (Miao and Metcalfe 2003; Gobel et al. 2004; Miao et al. 2005).
However, the increasing number of studies reporting the presence of metabolites
in the environment underlined the urge to include metabolites as an important
part of routine analysis of pharmaceuticals. For instance, several LC-MS
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methods have been developed to determine carbamazepine, one of the most
frequently detected pharmaceuticals in WWTP effluents and surface water, along
with its major phase I metabolites in aqueous samples (Miao and Metcalfe 2003;
Miao

et

al.

2005).

Interestingly,

metabolite

10,11-dihydro-10,11-

dihydroxycarbamazepine was found to be the dominant analyte which had a
concentration 3 to 4 times higher than that of carbamazepine in wastewater
(Miao and Metcalfe 2003). A significant increase of the parent drug was also
observed in the treated wastewater relative to concentrations in the untreated
wastewater, suggesting that some phase II metabolites could have been
transformed to free form by cleavage of the conjugates during the treatment. The
increase of the parent drug is likely related to the fact that hydroxylated
metabolites of carbamazepine occur primarily in conjugated forms such as
glucuronidation in body fluids (Miao et al. 2005). Therefore, it is increasingly
important to include phase II metabolites when assessing the occurrence, fate
and transport of pharmaceuticals in the environment.
1.8 Driving Hypothesis
The primary driver is the concern that long-term exposure to low levels of
pharmaceutical residues could have adverse effects on aquatic organisms.
1.9 Objectives
The main objectives of the present study are to develop sensitive and robust
analytical methods using mass spectrometry to investigate the occurrence of
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pharmaceuticals and metabolites in the environment, and to understand the
uptake and depuration of pharmaceuticals in biological tissues. The ultimate goal
is to assess the ecological risks associated with the exposure.
In chapter 2, an LC-MS/MS method for the analysis of 11 target pharmaceuticals
in biological tissues (fish), reclaimed water and surface water is described. BAFs
for the detected pharmaceuticals in mosquito fish sampled from a freshwater
pond directed affected by reclaimed water were calculated using the developed
method.
Chapter 3 describes the modification based on existing on-line SPE LC-MS/MS
to improve the throughput and to reduce carryover.
Chapter 4 explains the uptake and depuration as well as bioconcentration factors
of pharmaceuticals in reclaimed water by mosquito fish under worst-case
exposure scenario.
Chapter 5 describes the exploration of using liquid chromatography ultra-high
resolution Orbitrap mass spectrometry to identify and quantify phase II
pharmaceutical metabolites in reclaimed water.
In Chapter 6, the potential risks of five bioaccumulative pharmaceuticals
including caffeine, carbamazepine, diltiazem, diphenhydramine and ibuprofen
detected in reclaimed water were assessed using probabilistic approaches.
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CHAPTER 2
Analysis of selected pharmaceuticals in fish and the fresh water bodies
directly affected by reclaimed water using liquid chromatography-tandem
mass spectrometry
(Jian Wang, Piero Gardinali, Analytical and Bioanalytical Chemistry (2012)
404:2711–2720)
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2.1 Introduction
Because of increasing reports of their occurrence in water, wastewater, soil,
sediment and biosolids (Daughton and Ternes 1999; Heberer 2002; Boyd et al.
2003; Ramirez et al. 2007; Ramirez et al. 2009), pharmaceuticals including drugs
and their active metabolites have been recognized as emerging environmental
contaminants. Municipal wastewater has been identified as one of the main
routes bringing these pharmaceuticals into the environment (Daughton and
Ternes 1999). This is likely because wastewater treatment plants (WWTPs) are
not specifically designed to remove most of the pharmaceuticals, thus these
compounds are continuously released into reclaimed and surface waters in a
wide range of concentrations (Heberer 2002; Boyd et al. 2003). Fish are sensitive
indicators for substances that enter aquatic ecosystems (EPA 2009). Numerous
studies have shown that long-term exposure to pharmaceuticals and personal
care products (PPCPs) may result in accumulation of parent compounds, their
metabolites, or both in tissues of aquatic organisms, suggesting that further
studies on secondary effects of PPCPs on aquatic organisms are necessary
(Brooks et al. 2005; Tang et al. 2006; Chu and Metcalfe 2007; Ramirez et al.
2007; Berrada et al. 2008; Nakamura et al. 2008; Zhou et al. 2008; Ramirez et al.
2009; Smith et al. 2009).
On the basis of the complexity of environment matrices and the multiple
functionalities of emerging contaminants as target compounds, recently
described analytical protocols for the determination of PPCPs in both
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wastewaters (Segura 2007; Lajeunesse et al. 2008; Segura 2009) and biological
organisms (Tavazzi et al. 2002; Brooks et al. 2005; Chu and Metcalfe 2007;
Berrada et al. 2008) have focused on rather specific classes of compounds.
Antidepressants (Brooks et al. 2005; Chu and Metcalfe 2007; Lajeunesse et al.
2008) and antibiotics (Segura 2007; Berrada et al. 2008; Segura 2009) are the
two classes that have been studied the most. As the list of compounds found in
field collected fish samples expands, the need to develop simultaneous
screening methods for multiple classes of drug residues increases as well
(Balmer et al. 2004; Duedahl-Olesen et al. 2005; Buser et al. 2006; Rudel et al.
2006; Mottaleb et al. 2009). At present, the general approach employed for the
analysis

of

multi-class

pharmaceuticals

in

fish

involves

extraction

of

homogenized tissue with 1:1 mixture of 0.1 M acetic acid and methanol (Ramirez
et al. 2007), or acetonitrile combined with limited cleanup to back-extract lipid
material followed by liquid chromatography-mass spectrometry (LC-MS) analysis
(Smith et al. 2009). Additionally, the use of solid-phase microextraction (SPME)
techniques has also been explored as surrogates to estimate the potential
occurrence and uptake of pharmaceuticals in living fish by assuming similar
partition behavior between the SPME devices and the fish tissues placed in
contaminated environments (Zhou et al. 2008).
Accelerated solvent extraction (ASE) involving high pressure and temperature
has been shown to efficiently extract a wide range of compounds from fish
tissues (Draisci et al. 1998; Datta et al. 2002; Tavazzi et al. 2002; Wahlen 2004;
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Chu and Metcalfe 2007; Haglund et al. 2007; Berrada et al. 2008; Llorca et al.
2009; Losada et al. 2009; Lund et al. 2009). Meanwhile, HLB polymeric
cartridges are routinely used as SPE sorbent for cleanup of complex
environmental samples prior to LC-MS analysis. However, on the basis of
considerable variation in lipophilicity and pKa among different classes of
pharmaceuticals, optimum cleanup efficiency can be challenged by differential
retention behavior of target analytes on the sorbent. In contrast, mixed-mode
cation exchange (MCX) cartridges can accommodate both neutrals and cations
providing better selectivity during elution steps. For instance, Chu et al (Chu and
Metcalfe 2007) developed a method to determine paroxetine, fluoxetine and its
metabolite in fish tissue using accelerated solvent extraction followed by MCX
cleanup offering better recoveries and minimized matrix interferences. Because
of the capabilities mentioned above, mixed-mode MCX cartridges will likely
provide the needed retention for the multiple classes of pharmaceuticals
proposed herein.
The objectives of this study were to develop a comprehensive LC-MS/MS
method for the analysis of pharmaceuticals representing multiple therapeutic
classes in fish tissue, reclaimed and surface water, and to achieve better
sensitivity and recoveries for the determination of pharmaceuticals in biological
tissues by using a combination of accelerated solvent extraction followed by
mixed-mode SPE cleanup and LC-MS/MS detection.
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2.2 Experimental
2.2.1 Reagents, standards and solutions
The LC-MS grade methanol, water and formic acid used for mass spectrometry
analysis and the Optima grade methylene chloride and acetonitrile used for ASE
extraction were purchased from Fisher Scientific (Atlanta, GA). Distilled water for
SPE cleanup was purified and deionized with a Barnstead Nanopure water
purification system. Reference standards lincomycin, trimethoprim, caffeine,
sulfamethoxazole,

diphenhydramine,

diltiazem,

carbamazepine,

fluoxetine,

erythromycin, norfluoxetine and sertaline were purchased in the highest available
purity (Sigma-Aldrich, Milwaukee, WI). Five surrogates, covering the range of
functionalities were used for the method. Caffeine-13C3 was purchased from
Cambridge

Isotopes

Lab.

Inc.

(Andover,

MA).

Sulfamethoxazole-d4,

erythromycin-13C, d3 and paroxetine-d4 were purchased from Toronto Research
Chemicals Inc. (North York, Ontario). Carbamazepine-d10 was purchased from
C/D/N Isotopes Inc. (Pointe-Claire, Quebec). Fluoxetine-d6 was purchased from
Cerilliant Corp. (Round Rock, TX). All stock solutions and working solutions were
made in methanol and stored at -20°C in the dark to prevent degradation. The
0.1% formic acid solution used for mobile phase was prepared daily before
analysis. Ancillary solutions used as modifiers, i.e. acetic acid (pH 3.2), 5%
ammonium hydroxide in methanol and methanol:0.1% formic acid 50:50 (v/v)
were prepared daily.
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2.2.2 Sample collection and storage
Water and mosquito fish (Gambusia holbrooki) were collected from a freshwater
pond and a saltwater marsh located at Florida International University Biscayne
Bay Campus (North Miami Beach, FL). The saltwater tidal marsh is not impacted
by reclaimed water and is hydrologically connected with Biscayne Bay while the
freshwater pond is isolated from the tidal influence of the bay and continuously
receives storm water runoff and reclaimed water from a local WWTP through
daily sprinkler irrigation. Therefore, the organisms living in this pond are likely to
be chronically exposed to the contaminants from reclaimed water. Seven
composite mosquito fish samples were collected from each sampling site using
unbaited minnow traps deployed at depth between 20 and 30 cm. The sizes of
the fish collected in the traps ranged from 2.0-4.2 cm (total length) and
individuals weighed from 0.3-2.1 g. All tissue samples were brought to the
laboratory, sorted, classified and stored at or below -20 °C until time of analysis.
Fish were pooled to obtain at least 30 g of material and homogenized with a
ULTRA TURRAX IKA T18 stainless steel tissuemiser (Wilmington, NC) set to
rotate at 10,000 rpm. The homogenates were stored at -20 °C and thawed at 4°C
for approximately 10 h before extraction. Reclaimed water (1-Liter) was directly
drawn from irrigation sprinklers during a period of two months, while pond water
samples were collected in 1-Liter pre-cleaned amber glass bottles at the site
where fish were collected. All water samples were transported to the laboratory
and stored in dark at or below 4 °C until they were filtered and processed. Water
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extraction was conducted within 7 days of collection to prevent losses on the
basis of biodegradation.
2.2.3 Animal care and use
All animal experiments were conducted in accordance with the Institutional
Animal Care and Use Committee of Florida International University (#A3096-01).
2.2.4 Solid phase extraction for water samples
To remove suspended materials, water samples were filtered through 0.5 µm
pre-combusted glass fiber filters (GE Water & Process Technologies, Trevose,
PA) within 24 h after collection. 50 µL of surrogate standards solution were
added to each 250 mL of filtered reclaimed water or pond water sample. Oasis
HLB (3cc/60mg, Waters Corp., Franklin, MA) cartridges were conditioned with 3
mL of methanol followed by 3 mL of distilled water. Solid phase extraction was
performed on an ALLTECH 12-port vacuum manifold (Deerfield, IL). After the
samples had passed through the HLB cartridges, they were washed with 4 mL of
5% methanol in water prepared daily. The analytes were eluted with 3 mL of
methanol. Each methanol eluent was mixed with 50 µL of paroxetine-d4 internal
standard solution and evaporated to dryness under a gentle stream of purified
nitrogen gas. Dried residues were reconstituted with 200 µL of methanol:0.1%
formic acid 50:50 (v/v). After brief sonication and vortex, the samples were ready
for LC-MS/MS analysis.
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2.2.5 ASE extraction for fish tissues
Fish samples were extracted using a Dionex ASE 200 accelerated solvent
extraction system (Dionex Corp., Sunnyvale, CA). 25 g of Na2SO4 were placed in
the 33-mL stainless steel extraction cell containing a glass fiber filter in the outlet
side. Approximately 1 g of fish homogenate was placed on top of the Na2SO4.
Five surrogates including caffeine-13C3 (412.0 ng), Sulfamethoxazole-d4 (100.0
ng), carbamazepine-d10 (29.5 ng), fluoxetine-d6 (31.0 ng), and erythromycin-13C,
d3 (100.0 ng) were added to each sample. The cell was topped with another
glass fiber filter, firmly capped and extracted. Methylene chloride was employed
as the extraction solvent. The ASE conditions are as follows: oven temperature
80°C; pressure 1500 psi; heat for 5 min; 1 static cycle; static time 10 min; flush
volume 60% and purge for 120 sec. After each extraction cycle, 30 mL
methylene chloride extract was flushed into a 60-mL glass vial and dried under
gentle nitrogen stream. The dried extract was then reconstituted with 30 mL of
acetic acid (pH 3.2) in water. The glass vial was sonicated for 10 min and the
sample was ready for MCX-SPE cleanup.
2.2.6 Cleanup for fish tissues
3cc/60mg Oasis MCX cartridges (Waters Corp., Franklin, MA) were employed for
the fish extract cleanup. The cartridges were conditioned with 3 mL of methanol
followed by 3 ml of acetic acid in water (pH 3.2). Care was taken not to dry the
cartridges during loading process. A cartridge flow rate of less than 1 mL/min
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was operated under the vacuum of 20 psi. Once the samples had passed
through the cartridges, they were washed with 2 mL acetonitrile and dried for 5
min. The cartridges were then eluted with 3 mL of 5% ammonium hydroxide in
methanol. 50 µL of paroxetine-d4 internal standard solution were added, and
samples were dried using a centrifuge concentrator (Labconco Corp., Kansas
City, MO). 200 μL of methanol:0.1% formic acid 50:50 (v/v) were added to each
sample. After 10 min sonication and 1 min of vortex, samples were transferred
and analyzed by LC-MS/MS.
2.2.7 LC–MS/MS analysis
The liquid chromatography system consists of a Thermo PAL CTC autosampler
and a quaternary Thermo Scientific Accela pump. Analytes were separated on a
Hypersil GOLD 50 x 2.1 mm, 3 μm particle size and 175
Å pore size column,
from Thermo Scientific (Bellefonte, PA). A simple binary gradient consisting of A:
0.1% formic acid in water (v/v) and B: 100% methanol was employed for
chromatographic separation. The gradient was (methanol %): 0 min 3%, 4 min
3%, 10 min 97%, 13 min 3% and 16 min 3%. The flow rate was maintained at
300 μL/min. The injection volume was 20 μL.
All the samples were analyzed with a Thermo TSQ Quantum Access triple
quadrupole (QqQ) mass spectrometry equipped with a heated electrospray ion
source (HESI). Tandem mass spectrometry detection was performed in selected
reaction monitoring (SRM) mode. Collision energy (CE) and tube lens voltage for
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each compound were optimized through direct infusion into mass spectrometer
at concentration of 1 μg/mL and at the flow rate of 15 μL/min. Additional
instrumental parameters for all analytes were as follows: Spray voltage at 3500
V, Capillary temperature and Vaporizer temperature at 300 °C; Sheath gas (N2)
and Aux gas (N2) at 30 arbitrary units; Ion sweep gas (N2) at 10 arbitrary units.
Scan time was set to 0.5s. Precursor ions, product ions and SRM transition
parameters are listed in Table 2.1.

Table 2.1 SRM transition parameters
Collision
Compounds

SRM 1

energy

Collision
SRM 2

(V)

energy
(V)

lincomycin

407→126

31

407→359

18

trimethoprim

291→230

24

291→260

25

caffeine

195→138

18

195→110

21

sulfamethoxazole 254→156

17

254→108

29

diphenhydramine 256→167

15

256→152

40

diltiazem

415→178

25

415→150

39

carbamazepine

237→194

19

237→192

21

erythromycin

717→540

18

717→558

15

fluoxetine

310→148

8

310→44

12

norfluoxetine

296→134

6

296→31

46

sertraline

306→275

12

306→159

28
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2.2.8 Matrix effects
Matrix effects could have a severe detrimental effect in LC-MS/MS analysis
especially when coupled with ESI sources (Vanderford et al. 2003; Segura 2007).
Both signal suppression and enhancement are commonly observed on the basis
of co-eluting matrix interferences. The exact mechanism still remains unknown
but it has been widely discussed in previous work with respect to PPCPs
(Vanderford et al. 2003; Renew and Huang 2004; Segura 2007).
In order to evaluate matrix effects, replicates of clean fish tissues (1 g) were
extracted and cleaned up as described above. One of the extracts was spiked
with a known amount of analytes and surrogates and brought to a final volume of
200 μL with methanol:0.1% formic acid (50/50, v/v). Simultaneously, a
methanol:0.1% formic acid (50/50, v/v) solution spiked with the same
concentration of analytes and surrogates was analyzed as a matrix-free
reference sample. Matrix effects were evaluated using the following equation
(Segura 2007):

where Rm+s is the response ratio of the analyte in spiked matrix, Rm is the
response ratio of the analyte in unspiked matrix and R0 is the response ratio of
the analyte in matrix-free reference sample.
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2.3 Results and Discussion
The target compounds were selected based on the results of an EPA pilot study
for PPCPs in fish tissue (EPA 2009) and a previously reported PPCP screening
method (Ramirez et al. 2007). According to the EPA pilot study, carbamazepine,
diltiazem, diphenhydramine, fluoxetine, norfluoxetine and sertraline have been
detected in fish collected from 5 effluent-dominated streams in various regions of
the United States. Ramirez et al. (Ramirez et al. 2007) have also reported the
presence of diphenhydramine, diltiazem, carbamazepine and norfluoxetine in fish
collected from an effluent-dominated stream in Texas. In addition to the target
compounds mentioned above, other pharmaceuticals such as trimethorprim,
caffeine, sulfamethoxazole and erythromycin that have been routinely detected in
the reclaimed water used for ground irrigation at Florida International University
Biscayne Bay Campus (North Miami Beach, FL) were also included in this study
to assess potential accumulation from the reclaimed water (Wang and Gardinali
2012).
2.3.1 Mass spectrometry
In order to achieve similar ionization behavior as those expected during real
sample analysis, optimization of analyte responses was performed while the
mobile phase was infused along with the standard solution through a tee
connector at a speed of 50 μL/min. The most abundant molecular ion was
selected as the precursor ion for that particular analyte. With the exception of
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erythromycin, protonated [M+H]+ was found to be the most abundant precursor
ion for all analytes. [M+H–H2O]+ was found to be the most abundant precursor
ion for erythromycin which was in agreement with Hirsh et al.,(Hirsch et al. 1999)
who showed that erythromycin has already lost a water molecule when present in
the aquatic environment. Once the precursor ion has been identified, Q3 was
scanned to define product ions and to optimize the collision energy for each
compound. Two SRM transitions were selected to avoid false positives and to
give 4 identification points in accordance with EU Commission Decision
2002/657/EC (2009). All optimized parameters can be found in Table 1.
Both electrospray ionization (ESI) and heated electrospray ionization (HESI)
probes were tested to obtain optimal ionization efficiency. HESI is designed to
use ESI in combination with heated auxiliary gas that transforms ions in solution
into ions in the gas phase more efficiently. As shown in Figure 2.1, HESI probe
showed at least 2-4 times improvement over ESI for all the compounds, in
particular for early eluting compounds such as lincomycin, caffeine, and
trimethoprim mainly because of better peak shapes and narrower peak width.
Therefore, HESI was selected as the ion source in this study.
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Figure 2.1 Representative chromatograms of all selected pharmaceuticals
standards on HESI (A) and ESI (B) sources at the same spiking level

2.3.2 Accelerated solvent extraction for fish tissues
The most commonly used methods for extracting multiclass pharmaceuticals
from fish tissues involve sonicating or vigorously shaking tissue homogenates
with organic solvents such as acetonitrile and methanol followed by direct LC-MS
analysis (Tang et al. 2006; Ramirez et al. 2007; EPA 2009; Smith et al. 2009).
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However, in order to improve the extraction efficiency and method throughput,
ASE was used because of its advantages over traditional methods, including
automated extraction, higher recoveries, and smaller volume of extraction
solvents (Draisci et al. 1998; Datta et al. 2002; Tavazzi et al. 2002; Wahlen 2004;
Chu and Metcalfe 2007; Haglund et al. 2007; Berrada et al. 2008; Llorca et al.
2009; Losada et al. 2009; Lund et al. 2009). The first challenge when developing
ASE method is to choose the appropriate extraction solvent. Various solvents
including methanol, acetone, acetonitrile, and methylene chloride were tested for
fish homogenate samples (1 g) fortified with all the analytes. The final selection
of the extraction solvent was based on the “absolute recovery” calculated by
subtracting the peak area of unspiked sample from that of the spiked sample.
Absolute recoveries in different solvent systems are shown in Figure 2.2, where
methylene chloride showed the highest absolute recoveries for all the analytes
except for lincomycin and erythromycin. Other ASE conditions such as oven
temperature, pressure, static time and cycles, heat-up time and flush volume
were selected with slight modifications according to previously reported methods
(Chu and Metcalfe 2007).
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Figure 2.2 ASE solvent selection based on absolute recoveries
2.3.3 SPE cleanup
Although trace analysis at ng/g level can be achieved when using mass
spectrometry as the detection method, matrix effects are still problematic on the
basis of co-eluting matrix components during the extraction procedures without
additional cleanup steps (Ramirez et al. 2007; EPA 2009). Gel permeation
chromatography (GPC) is generally applied to remove lipid contents from
biological tissues. However, this method requires large volume of organic solvent
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and an extra cleanup step is still needed to make the sample suitable for LC-MS
analysis (Chu and Metcalfe 2007). In contrast, mixed mode cation-exchange
(MCX) SPE has been shown to be a successful alternative to cleanup
complicated matrices such as fish tissues while still maintaining optimum
recoveries of analytes with considerable ranges of pKa and lipophilicity (Chu and
Metcalfe 2007). MCX cartridges can provide much cleaner extract than regular
HLB cartridges because organic solvents such as methanol or acetonitrile can be
used to wash cartridges and eliminate interferences without losing the selectively
retained analytes for further elution. The only requirement is that the samples
need to be acidified in order for analytes to be retained on the sorbent by cation
exchange reactions. In addition, care must be taken during the pH adjustment
because analytes could be lost during the loading and washing steps if the pH is
too low (Chu and Metcalfe 2007). On the basis of the fact that sulfamethoxazole
has the lowest pKa of 5.8 among all the analytes (Qiang and Adams 2004), ASE
extract was adjusted with acetic acid to pH 3.3 which is approximately 2 units
below the pKa of sulfamethoxazole. Five solvents including methanol,
acetonitrile, acetone, methylene chloride and hexane:methylene chloride (50/50,
v/v) mixture were tested as the wash solvents. Individual analyte recoveries in
each solvent system are plotted in Figure 2.3, where error bars represent
standard deviations from average recoveries (n=3). Because acetonitrile is a
stronger eluent than methanol (Nelis 1983), higher recoveries were expected
from the methanol wash. However, acetontitrile was found to be the most
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effective solvent at removing interferences from the cartridge while offering
maximum recovery and good overall precision.
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Figure 2.3 Averaged (n=3) individual analyte recoveries in each wash solvent
system
2.3.4 Matrix effects
All compounds were analyzed for potential matrix effects in HESI positive mode
and results are shown in Table 2.2 along with the statistically derived MDLs
(n=7). Positive values indicate signal enhancement and negative values indicate
signal suppression on the basis of the matrix effects. As shown in Table 2.2,
caffeine and erythromycin showed moderate signal enhancements. Similar
results were also observed by Ramirez et al. (Ramirez et al. 2007). Other
compounds showed various degrees of signal suppression.
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Table 2.2 Observed MDLs Matrix Effects and recoveries in fish tissue
MDL (ng/g)

Ramirez’s MDL(ng/g)

Matrix Effects

(Ramirez et al. 2007)

(%)

Recovery (%)

lincomycin

1.05

5.53

–38 ± 0.2

63 ± 8

trimethoprim

1.03

2.15

–65 ± 1

83 ± 4

caffeine

0.81

3.93

33 ± 3

64 ± 13

sulfamethoxazole

0.84

2.29

–54 ± 1

44 ± 4

diphenhydramine

0.08

0.05

–40 ± 1

85 ± 4

diltiazem

0.11

0.12

–95 ± 1

60 ± 16

carbamazepine

0.10

0.54

–26 ± 0.4

61 ± 0.5

erythromycin

0.51

6.42

20 ± 0.5

28 ± 0.4

fluoxetine

1.19

6.73

–5 ± 5

66 ± 12

norfluoxetine

0.41

2.90

–42 ± 5

19 ± 10

sertraline

0.26

3.57

–26 ± 2

80 ± 1
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For water samples, matrix effects were evaluated using the same procedure as
for fish tissues (Table 2.3). Organic matter in surface waters has shown to play
an important role on matrix effects (Renew and Huang 2004). The overall results
indicate that reclaimed water showed more pronounced effects than pond water
for most of the compounds. Signal enhancement was observed on 7 compounds
in reclaimed water samples while only 2 compounds showed signal
enhancement in the pond water samples.
2.3.5 Analytical performance
Analyte concentrations in fish tissues were determined based on response
factors (RFs) of the target compounds relative to the surrogate internal
standards. This approach can be used for most trace analysis, as it doesn’t
require blank matrix and greatly alleviates the signal suppression or
enhancement arising from matrix effects that can affect the sensitivity and
response of the mass spectrometer in unpredictable ways.
Method detection limits (MDLs) were used to evaluate the analytical performance
in different matrices and reported in Table 2.2 and Table 2.3. MDL represents the
lowest concentration of the analyte that can be measured and reported with 99%
confidence in a given matrix is greater than zero (1986). It has been discussed
and generally assumed that experimentally derived MDLs in a given matrix are
appropriate for establishing detection threshold in environmental analysis
(Ramirez et al. 2007; Mottaleb et al. 2009; Ramirez et al. 2009).
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Table 2.3 Observed MDLs matrix effects and recoveries in pond water and reclaimed water
Pond Water
MDL
(ng/L)

Matrix
Effects
(%)

Reclaimed Water

Recovery

MDL

(%)

(ng/L)

Matrix
Effects

Recovery (%)

(%)

lincomycin

3.3

263±14

136±14

10.9

268±59

152±12

trimethoprim

2.6

64±2

101±6

266

74±6

69±4

caffeine

7.6

-7±6

101±8

348

33±6

75±13

sulfamethoxazole

4.6

-14±3

104±5

67.5

9±4

94±14

diphenhydramine

0.4

-41±0.8

82±1

53.1

-18±0.3

79±1

diltiazem

0.2

-36±3

68±0.7

26.9

-49±4

83±0.2

carbamazepine

1.5

-18±1

90±5

17.8

26±7

117±23

erythromycin

15

-2±4

112±2

88.0

35±3

115±8

fluoxetine

3.4

-3±4

95±6

5.0

7±0.9

86±0.1

norfluoxetine

1.0

-44±2

32±2

1.8

-25±2

21±0.1

sertraline

1.2

-9±3

56±0.6

4.9

-2±2

40±0.6
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Seven replicates of 1 g of clean fish tissues (n=7) were spiked with an
appropriate amounts of analytes (for spike levels see Table 2.4) and extracted as
described above. Similarly, seven replicates of 250 mL pond water and 250 mL
reclaimed water were spiked at the same level and subjected to the SPE-LCMS/MS analysis. MDLs were then calculated by multiplying the one-side
student’s t-value at 99% confidence by the sample standard deviation derived
from the concentrations of 7 replicate spiked samples (1986). Concentrations
below MDLs were reported as “not detected”. Compared to the previous studies
(Ramirez et al. 2007), the protocol demonstrated here offers cleaner fish extracts
giving lower MDLs for 10 out of 11 selected compounds. The MDL for
diphenhydramine was slightly higher but similar to the value reported by Ramirez
et al. (Ramirez et al. 2007). Concentrations of diphenhydramine detected in fish
tissues, however, were considerably higher than the calculated MDL. For water
samples, MDLs in reclaimed water were significantly higher than those in pond
water because of both a more complicated matrix and higher overall
concentrations that produced larger standard deviations. The recoveries of
norfluoxetine were found at 19% in fish, 32% in pond water and 21% in reclaimed
water, respectively. The low recovery is likely on the basis of the lack of methyl
group in norfluoxetine increasing the water solubility compared to fluoxetine.
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Table 2.4 Fortification levels for matrix effect assessment, recovery calculation and MDL
determination in fish tissues and water samples
fortification levels in fish tissues (ng/g)
Matrix
effect
assessment

Recovery

MDL

calculation determination

fortification levels in water (ng/L)
Matrix
effect
assessment

Recovery

MDL

assessment determination

lincomycin

9.9

9.9

1.0

40.0

40.0

4.0

trimethoprim

9.9

9.9

1.0

40.0

40.0

4.0

caffeine

39.9

39.9

4.0

160

160

16.0

sulfamethoxazole

39.9

39.9

4.0

160

160

16.0

diphenhydramine

2.0

2.0

0.2

8.0

8.0

0.8

diltiazem

2.0

2.0

0.2

8.0

8.0

0.8

carbamazepine

4.0

4.0

0.4

16.0

16.0

1.6

erythromycin

20.1

20.1

2.0

80.4

80.4

8.0

fluoxetine

60.0

60.0

6.0

240

240

24.0

norfluoxetine

30.0

30.0

3.0

120

120

12.0

sertraline

19.9

19.9

2.0

80.0

80.0

8.0
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2.3.6 Analysis of environmental samples
Mosquito fish (Gambusia holbrooki) sampled from a saltwater marsh not
influenced by reclaimed water and a freshwater pond affected by reclaimed water
influence were analyzed for target analytes. Reclaimed water and pond water
samples collected over a period of 2 months were also concurrently analyzed.
Concentrations of target analytes in water samples are summarized in Table 2.5.
73% of target compounds were consistently detected in reclaimed water
samples. However, fluoxetine, diltiazem and erythromycin were not detected in
the pond water influenced by reclaimed water. The possible explanation is that
these compounds can be rapidly dissipated from the water phase as a result of
adsorption to sediment where they seem to be persistent (Andrisano et al. 2001;
Kwon and Armbrust 2005; Davis et al. 2006; Kwon and Armbrust 2006).
Therefore, it is not surprising that neither fluoxetine nor diltiazem was detected in
fish tissues in this study even though they have been reported to accumulate in
fish (Brooks et al. 2005; Chu and Metcalfe 2007; Ramirez et al. 2007). As shown
in Table 2.6, caffeine, diphenhydramine and carbamazepine were detected in
fish tissues from the freshwater pond but no target compounds were detected in
those from the saltwater marsh. Bioaccumulation factors for caffeine,
diphenhydramine and carbamazepine in mosquito fish (Gambusia holbrooki)
were calculated accordingly and found at 29 ± 26 , 821 ± 422 and 108 ± 144,
respectively. The calculated BAF for carbamazepine was consistent with
literature value (Vernouillet et al. 2010). All the resulting BAFs were higher than
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those calculated based on log Kow (octanol/water partition coefficient) (Duffy and
Jorgensen 2000) and EPA Kow based Aquatic BioAccumulation Model (KABAM)
(1 for caffeine, 93 for diphenhydramine and 14 for carbamazepine) (2009; EPA
2009). Upon plotting a graph of BAF vs log Kow, a positive relationship was
observed (R2=0.5665) which was consistent with previously proposed theory
(Gossett et al. 1983). While diphenhydramine and carbamazepine have been
previously observed in fish tissues (Ramirez et al. 2007), potential accumulation
of caffeine in fish is reported here for the first time.
2.4 Conclusions
This study presents the development of a new method for the analysis of
selected pharmaceuticals in fish tissue, reclaimed water and surface water
directly affected by reclaimed water. Compared to previous methods, accelerated
solvent extraction followed by MCX mixed-mode SPE cleanup provided a better
alternative on the basis of cleaner extracts giving lower method detection limits.
73% and 45% of all target compounds were consistently detected in reclaimed
water and

surface water,

respectively. Caffeine, diphenhydramine

and

carbamazepine were detected in mosquito fish from the freshwater pond directly
affected by reclaimed water influence but they were not detected in those from
the saltwater mash. Bioaccumulation factors for caffeine, diphenhydramine and
carbamazepine in mosquito fish were also calculated and found at 29 ± 26, 821 ±
422 and 108 ± 144, respectively.
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Table 2.5 Summary of concentrations of target compounds in reclaimed water and pond
water
Compounds

Reclaimed water (ng/L) n=17
Mean

sd

Pond water (ng/L) n=9

Max

Min Median

Mean

ND

ND

ND

ND

lincomycin

ND

trimethoprim

338

273

920

16

254

1.3

caffeine

1476

1177 4315

53

1217

sulfamethoxazole

241

128

409

3.0

diphenhydramine

89

48

179

diltiazem

29

30

carbamazepine

97

erythromycin

sd

Max Min Median
ND

ND

ND

3.7

11

ND

ND

81

48

172

23

63

263

8.0

5.2

14

ND

10

6.3

77

0.67

0.38

1.3

ND

0.62

111

ND

22

ND

ND

ND

ND

55

229

20

83

4.5

6.6

1.9

5.4

79

37

141

ND

88

ND

ND

ND

ND

fluoxetine

9.7

5.4

24

ND

9.7

ND

ND

ND

ND

norfluoxetine

ND

ND

ND

ND

ND

ND

ND

ND

sertraline

ND

ND

ND

ND

ND

ND

ND

ND

ND: less than MDL
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Table 2.6 Concentrations (ng/g) of target compounds detected in
fish tissue (n=7) from the freshwater pond
Compounds

Mean

sd

Max

Min

Median

lincomycin

ND

ND

ND

ND

trimethoprim

ND

ND

ND

ND

caffeine

1.3

4.5

ND

1.2

sulfamethoxazole

ND

ND

ND

ND

diphenhydramine

0.55

0.97

0.08

0.59

diltiazem

ND

ND

ND

ND

carbamazepine

0.20

0.66

ND

0.10

erythromycin

ND

ND

ND

ND

fluoxetine

ND

ND

ND

ND

norfluoxetine

ND

ND

ND

ND

sertraline

ND

ND

ND

ND

1.6
0.27
0.25

ND: less than MDL
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CHAPTER 3
Improving sample throughput and reducing carryover by reprogramming
the CTC autosampler for on-line LC-MS/MS analysis using the EQuan
system
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3.1 Introduction
As the list of pharmaceutically active compounds being reported in various
environmental matrices keeps growing, it is obvious that there is a need to
develop new analytical techniques that are more effective at analyzing multiple
components in a large number of samples in limited time (Balmer et al. 2004;
Buser et al. 2006; Mottaleb et al. 2009). Various solid phase extraction (SPE)
methods combined with GC-MS and GC-MS/MS (Sacher et al. 2001; Mottaleb et
al. 2009; Ramirez et al. 2009), or more recently, LC-MS/MS (Renew and Huang
2004; Lajeunesse et al. 2008; Wang and Gardinali 2012) have been successfully
developed to identify and quantify multiple classes of pharmaceuticals in
aqueous matrices. The SPE procedures used can be very effective at removing
matrix components and concentrating samples to achieve desired sensitivity.
However, the preparation requires processing large sample volumes commonly
ranging from 200 mL to 1 L (Lajeunesse et al. 2008; Wang and Gardinali 2012),
which makes it time consuming and laborious.
In order to address the needs for lower detection limits and higher sample
throughput, an on-line SPE coupled to mass spectrometry detection was
developed to eliminate several preparation steps such as evaporation and
reconstitution (Segura 2007; Garcia et al. 2009; Wang and Gardinali 2012). The
new protocol was successfully applied to screening and detecting of a variety of
environmental contaminants including pharmaceuticals, endocrine disruptors and
groups of pesticides (Segura 2007; Garcia et al. 2009). More recently, on-line
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SPE LC-MS/MS has become a more desired technique in routine analysis of
aqueous samples, especially for samples that are time sensitive and need large
injection volume.
As shown in Figure 3.1, the time for a typical on-line SPE LC-MS/MS analysis
consists of autosampler preparation time, sample withdraw time, SPE sample
loading and elution time, and chromatography separation time. On the basis of
the fact that loading speed is at 1 mL/min, total run times could be quite long
when large sample volume (i.e. 20-50 mL) is used to improve detection limits. To
shorten the time between injections, “look ahead” mode can be enabled so that
the autosampler sets up for the next injection during the current run. Although the
“look ahead” injection mode can be used to incorporate autosampler preparation
and sample withdraw time into chromatography time, the sample is still aspired
into the sample loop during the next run cycle. In addition, the dead volume of
large sample loops (>5 ml) creates a considerable delay of gradient changes and
increases the uncertainty of mobile phase mixing.
In this chapter, default autosampler program commands were modified from 1draw sample, 2-move to injection port, 3-aspire sample, 4-inject and 5-washing to
1-inject, 2-wait, 3-switch injection valve to load, 4-washing, 5-draw sample, 6move to injection port, and 7-aspire sample (Figure 3.2). The amount of time that
the modified autosampler program took was compared with those needed for the
default injection mode and “look ahead” mode. Efficiencies for the washing steps
of injection syringe and sample loop which lead to carryover were also
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investigated among the default autosampler program, look ahead, and the
modified autosampler program for all the compounds in laboratory routine
analysis of water samples.

1 min
Preparation time

4 min
Sample
withdraw time

4 min
Sample
inject time

5 min

10 min

SPE loading
& elution time

separation time

Typical program
SPE loading
& elution
time

Sample
inject time

Preparation time

separation time

Sample
withdraw time

Look ahead
SPE loading
& elution
time
Preparation time

separation time

Sample
withdraw time

Sample
inject time

Modified program

Figure 3.1 Comparison of run times among a typical program, look ahead and
the modified program for a 20 mL on-line EQuan injection with 10 min separation
time
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Figure 3.2 Valve configurations and CTC autosampler commands in a typical autosampler program and the new
autosampler program
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3.2 Experimental
3.2.1 Reagents, standards and solutions
The sources and stock solution preparation of all reference standards were the
same as those described in Chapter 2. The LC-MS grade methanol, water and
formic acid used for mass spectrometry analysis were purchased from Fisher
Scientific (Atlanta, GA). The 0.1% formic acid solution used for mobile phase was
prepared daily before analysis.
3.2.2 Instrumentation
A Thermo EQuan online SPE system was used in this study. The HPLC system
consists of two pumps: Accela 1000 was used as the analytical pump and Accela
600 was used as the loading pump (Thermo Scientific, San Jose, CA). A Hypersil
GOLD 20 mm × 2.1 mm, 12 µm preconcentration column (Thermo Scientific, San
Jose, CA) was used as the loading column. The analytical separation was carried
out using a Hypersil GOLD column (150 mm × 3.0 mm, 3 µm). A CTC-PAL
autosampler (Thermo Scientific, San Jose, CA) with “Macro editing” function
enabled was equipped to perform 5 mL injections. The autosampler was
reprogrammed by rearranging the “commands” in “Macros” which work as the
building blocks of the autosampler program. All the samples were analyzed with
a Thermo TSQ Quantum Access triple quadrupole (QqQ) mass spectrometry
equipped with a heated electrospray ion source (HESI). Tandem mass
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spectrometry detection was performed in selected reaction monitoring (SRM)
mode. Instrument control and data acquisition was performed using the software
Xcalibur 2.1 (Thermo Scientific, San Jose, CA).
3.2.3 Working principle of EQuan system
The scheme of a typical online SPE setup based on column-switching is shown
in Figure 3.3. The working procedure consists of switching a 6-position divert
valve on the mass spectrometer which is programmed by the data system to
control the loading and elution of the two LC columns. At the “Load” position, 5
mL of sample was injected into a 5 mL loop and then loaded onto the SPE
column by the loading LC pump (Accela 600), followed by a wash step to remove
interferences. The sample was preconcentrated and target compounds were
retained on the SPE column while the rest of sample along with matrix was
directed to waste. Next, the analytical pump equilibrated the analytical column
with starting gradient conditions for the analytical run. Once the sample loading
completed, the valve switched to the “Inject” position reversing the solvent flow
through the loading column and back flushing analytes onto the analytical column
for separation. After a certain amount of time depending upon the gradients, the
switching valve returned to the load position to allow the loading column to be reequilibrated.
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Figure 3.3 Scheme of on-line SPE EQuan system based on column-switching
3.3 Results and discussions
Despite having the advantages of improved detection limits and simpler sample
preparation steps, on-line EQuan system still suffers from the problems
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associated with extended injection volume if a typical injection program is used.
First of all, insufficient washing of the sample loop can lead to carryover. This
generally will not become an issue for small volume direct injections as the
sample loop (10-50 µL) would have been thoroughly flushed many times by the
mobile phase passing through it. On the other hand, the EQuan system consists
of a sample loop that is so large (>5 mL) that the sample loop would not be
completely flushed before the autosampler draws the next sample, which
subsequently leads to carryover. Secondly, unlike the negligible dead time of a
direct injection system, one should take into account the dead time that a large
sample loop creates because it could be up to several minutes depending on the
size of the sample loop and the flow rate of mobile phase. Lastly and most
importantly, the total run time could be quite long when an even larger sample
volume (e.g., 20 mL) is used to improve detection limits. An example of a 20 mL
injection will be discussed below and the run times were compared among a
typical autosampler program, look ahead and the modified program.
As shown in Figure 3.1, a typical 20 mL on-line EQuan injection with a 10 min of
separation time consists of 1 min of preparation time, 4 min of sample withdraw
time, 4 min of sample inject time, and 5 min of SPE loading and elution time.
Because this multi-sampling scheme can be quite time consuming, the ability to
perform “look-ahead” injections allows for significant time savings. The
autosampler will take the subsequent sample in sequence while the mass
spectrometer is analyzing the previous sample. Although “look ahead” injections
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can be used to incorporate autosampler preparation and sample withdraw time
into chromatography time, a sample is still aspired into the sample loop during
the next run cycle. In addition, “look ahead” does not modify the configuration of
sample loop, thus the considerable gradient delay and potential carryover are still
present.
To address this situation, the current CTC autosampler program was modified
from 1-draw sample, 2-move to injection port, 3-aspire sample, 4-inject and 5washing to 1-inject, 2-wait, 3-switch injection valve to load, 4-washing, 5-draw
sample, 6-move to injection port, and 7-aspire sample (see Figure 3.2). With this
program, the “inject” command simultaneously triggers both data acquisition and
injection valve to switch to the inject position. The sample driven by the mobile
phase is then loaded onto the loading column. After waiting for a period of time
that is long enough for the entire sample to pass through the sample loop, the
injection valve is switched back to the load position which shorts the sample loop
out of the system. At this point, sample loop can be thoroughly flushed with
strong organic solvents such as methanol and acetonitrile resulting a more
efficient washing and less carryover. Once the syringe and sample loop have
been washed with solvents, the autosampler takes the next sample and aspires it
into the sample loop waiting for analysis. In each sequence, the first sample
consisting of mobile phase is used to equilibrate the system and to clean the
sample loop from previous users. For a 10 min-chromatography separation, up to
34% run time could be saved compared to the typical program and up to 25%
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when compared to the already optimized “look ahead” option. A total of 79% of
the selected pharmaceuticals had less carryover when compared to the
traditional on-line LC-MS/MS analysis.
3.4 Conclusions
The new program incorporates the autosampler preparation time, sample
withdraw and aspiration time into the load and chromatography time, resulting in
significantly shortened run time for longer sequences. For a 10 minchromatography separation, up to 34% and 24% of less run time can be saved
than the typical program and “look ahead”, respectively. The greatly reduced
dead volume of the system also prevents the delay of gradient changes and
allows for more efficient washing of samples on the loading column before
transferring to the analytical column.
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CHAPTER 4
Uptake and depuration of pharmaceuticals in reclaimed water by mosquito
fish (Gambusia holbrooki): A worst case multiple exposure scenario
(Jian Wang, Piero Gardinali, Environmental Toxicology and Chemistry, in press)
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4.1 Introduction
Human pharmaceuticals and their metabolites enter the environment primarily
through wastewater discharge on the basis of the limited removal procedures in
traditional wastewater treatment plants (WWTPs) (Daughton and Ternes 1999;
Ruhoy and Daughton 2008). Although concentrations in environmental water
bodies are typically at ng/L to low µg/L level, these organic pollutants may still
pose risks to aquatic species under chronic long-term exposure (Owen et al.
2007; Gunnarsson et al. 2008). For instance, after a 21-day exposure, fluoxetine
was shown to induce vitellogenin in male fathead minnows (Pimephales
promelas) at 28 ng/L and venlafaxine caused mortality of fathead minnows at
concentration as low as 305 ng/L (Schultz et al. 2011). Similarly, plasma samples
from the rainbow trout (Oncorhynchus mykiss) exposed to sewage effluents were
analyzed for 25 pharmaceuticals, of which levonorgestrel was detected in fish
plasma at concentrations (8.5-12 ng/mL) exceeding the human therapeutic
plasma level (Fick et al. 2010). Because many aquatic species were shown to
have similar physiological receptors to those the pharmaceuticals are originally
intended to react with in humans (Owen et al. 2007; Gunnarsson et al. 2008), the
data suggested a high risk of pharmacological effects on rainbow trout (Fick et al.
2010). Another study concerning the uptake and depuration as well as
bioconcentration factors (BCFs) of pharmaceuticals including moclobemide, 5fluoruracil, carbamazepine, diazepam, carvedilol and fluoxetine was conducted in
freshwater shrimp (Gammarus pulex) and water boatman (Notonecta glauca)

51

after a 2-day uptake phase (Meredith-Williams et al. 2012). The results showed
that BCFs in freshwater shrimp were significantly higher than those found in
water boatman, implying that pharmaceuticals may possess even higher risks to
smaller aquatic species as environmental pollutants. Recently, I reported that 8
pharmaceuticals

including

trimethoprim,

caffeine,

sulfamethoxazole,

diphenhydramine, diltiazem, carbamazepine, erythromycin, and fluoxetine were
consistently detected in reclaimed water used for daily irrigation at Florida
International University Biscayne Bay Campus (North Miami Beach, FL) (Wang
and Gardinali 2012; Wang and Gardinali 2012). All these pharmaceuticals are
unintentionally released to a freshwater pond through daily irrigation and some of
them partition and accumulate in mosquito fish (Gambusia holbrooki) living in this
pond (Wang and Gardinali 2012). Therefore, it is expected that aquatic systems
like this freshwater pond influenced by substantial inputs of reclaimed water may
represent a good model to study the exposure of biological resources to mixtures
of pharmaceuticals under relatively natural conditions (Brooks et al. 2006).
In addition, pharmacokinetic data describing the uptake and depuration of
pharmaceuticals by aquatic species are extremely limited compared to those in
mammals (Paterson and Metcalfe 2008; Meredith-Williams et al. 2012), thus it is
important to study the uptake and depuration rates in systems that may represent
“worst case exposure” without compromising the environmental relevance (Fick
et al. 2010). Most aquatic monitoring studies designed to simulate exposure
under environmentally relevant concentrations were performed in artificially clean
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matrices (Nakamura et al. 2008; Paterson and Metcalfe 2008; Hoang et al. 2011;
Meredith-Williams et al. 2012), often with exposure concentrations still higher
than those would be found under natural conditions by one or more orders of
magnitude (Paterson and Metcalfe 2008; Hoang et al. 2011). Although this
approach maximizes the chances of quantifying any compounds that might
accumulate with confidence, results are often not in good agreement with those
from the field (Nakamura et al. 2008; Paterson and Metcalfe 2008; MeredithWilliams et al. 2012). Reclaimed water produced by conventional primary and
secondary treatment offers good surrogacy for a worst case exposure scenario
and could be used to predict the extent of bioconcentration and toxicological
thresholds in aquatic organisms without resourcing to unrealistic concentrations
(Paterson and Metcalfe 2008). Moreover, to my knowledge, this is the first study
using a non-artificial exposure matrix to assess uptake and depuration kinetics
and bioconcentration factors (BCFs) in a highly relevant aquatic species for
South Florida protected environments.
4.2 Materials and methods
4.2.1 Reagents, standards and solutions
LC-MS grade methanol, water and formic acid used for mass spectrometry
analysis and SPE extraction, and the Optima grade methylene chloride used for
ASE extraction were purchased from Fisher Scientific (Bridgewater, NJ). The 0.1%
formic acid used as mobile phase was prepared daily. The sources for all 43
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pharmaceuticals and surrogate standards along with key physicochemical
parameters (Log Kow) are shown in Table 4.1. All stock solutions (100 ppm) and
working solutions were made in methanol and stored in the dark at –20 °C.
4.2.2 Organism husbandry and exposure conditions
A total of 117 mosquito fish (Gambusia holbrooki) weighing from 0.13 to 1.45
grams in mass and measuring from 2.5 to 5.2 cm in total length were purchased
from Carolina Biological Supply Company (Burlington, NC). Upon arrival, all fish
were maintained in two 70-Liter glass aquaria filled with dechlorinated tap water
(approximately 60 fish in each aquarium) for 14 days at 26.1 ± 0.7 °C under a
14:10h light:dark cycle. All experiments were conducted in accordance with the
Institutional Animal Care and Use Committee of Florida International University
(#A3096-01). In order to minimize the variability of concentrations in the
reclaimed water and to avoid possible losses on the basis of photo-degradation,
a total of 160 liters of reclaimed water were collected from the reclaimed water
outlet at Florida International University Biscayne Bay Campus (North Miami, FL)
and kept in dark at 16 °C. Water quality parameters including salinity, pH and
dissolved oxygen were monitored throughout the experiments using an YSI 556
MPS Multi Probe System (YSI Incorporated, Yellow Springs, Ohio).
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Analytes

Table 4.1 Identity, source and physicochemical parameters (Log Kow) for all compounds used in the study
Name

Log KOW a

Source

Naproxen

3.10

Sigma-Aldrich (Milwaukee, WI)

Ibuprofen

3.79

Sigma-Aldrich (Milwaukee, WI)

Diclofenac

4.02

MP Biomedicals, LLC. (Santa Ana, CA)

Mefenamic acid

5.28

Sigma-Aldrich (Milwaukee, WI)

Salicylic acid

2.24

Sigma-Aldrich (Milwaukee, WI)

Codeine

1.28

Cerilliant Corp. (Round Rock, TX)

Gemfibrozil

4.77

Sigma-Aldrich (Milwaukee, WI)

Bezafibrate

4.25

Sigma-Aldrich (Milwaukee, WI)

Phenobarbital

1.33

Sigma-Aldrich (Milwaukee, WI)

Butalbital

1.87

Sigma-Aldrich (Milwaukee, WI)

Fenofibrate

5.19

Sigma-Aldrich (Milwaukee, WI)

Atorvastatin

6.36

American Radiolabeled Chemicals,Inc. (Saint Louis, MO)
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Mevastatin

4.32

Sigma-Aldrich (Milwaukee, WI)

Pravastatin

3.10

Sigma-Aldrich (Milwaukee, WI)

Fluoxetine

4.65

Sigma-Aldrich (Milwaukee, WI)

Paroxetine

3.95

Sigma-Aldrich (Milwaukee, WI)

Sertraline

5.29

Sigma-Aldrich (Milwaukee, WI)

Diazepam

2.70

Cerilliant Corp. (Round Rock, TX)

Lorazepam

2.41

Cerilliant Corp. (Round Rock, TX)

Carbamazepine

2.25

Sigma-Aldrich (Milwaukee, WI)

Diphenhydramine

3.11

Sigma-Aldrich (Milwaukee, WI)

Atenolol

-0.03

Sigma-Aldrich (Milwaukee, WI)

Sotalol

-1.89

Toronto Research Chemicals Inc. (North York, Ontario)

Metoprolol

1.69

Sigma-Aldrich (Milwaukee, WI)

Propranolol

2.60

ACROS organics (Morris Plains, NJ)

Betaxolol

2.98

Sigma-Aldrich (Milwaukee, WI)
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Carazolol

2.66

Toronto Research Chemicals Inc. (North York, Ontario)

Pindolol

1.48

Sigma-Aldrich (Milwaukee, WI)

Nadolol

1.17

Sigma-Aldrich (Milwaukee, WI)

Salbutamol

0.64

Sigma-Aldrich (Milwaukee, WI)

Clenbuterol

2.00

Sigma-Aldrich (Milwaukee, WI)

Enalapril

2.45

Sigma-Aldrich (Milwaukee, WI)

Diltiazem

2.79

Sigma-Aldrich (Milwaukee, WI)

Tamoxifen

6.30

ACROS organics (Morris Plains, NJ)

Metronidazole

-0.02

ACROS organics (Morris Plains, NJ)

Clotrimazole

6.26

Sigma-Aldrich (Milwaukee, WI)

Glibenclamide

4.79

Sigma-Aldrich (Milwaukee, WI)

Caffeine

0.16

Sigma-Aldrich (Milwaukee, WI)

Sulfamethoxazole

0.48

Sigma-Aldrich (Milwaukee, WI)

Trimethoprim

0.73

Sigma-Aldrich (Milwaukee, WI)
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Surrogate internal standards

Lincomycin

0.29

Sigma-Aldrich (Milwaukee, WI)

Erythromycin

2.48

Sigma-Aldrich (Milwaukee, WI)

Norfluoxetine

4.07

Sigma-Aldrich (Milwaukee, WI)

[2H3]Ibuprofen

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H10]Carbamazepine

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H3, 13C]Erythromycin

N/A

Toronto Research Chemicals Inc. (North York, Ontario)

[13C3]Caffeine

N/A

Cambridge Isotopes Lab. Inc. (Andover, MA)

[2H4]Sulfamethoxazole

N/A

Toronto Research Chemicals Inc. (North York, Ontario)

[2H4]Diclofenac

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H3]Mefenaimic acid

N/A

Toronto Research Chemicals Inc. (North York, Ontario)

[2H4]2-hydroxybenzoic acid

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H6]Codeine

N/A

Cerilliant Corp. (Round Rock, TX)

[2H5]Atorvastatin

N/A

Toronto Research Chemicals Inc. (North York, Ontario)

[2H3]Pravastatin

N/A

Toronto Research Chemicals Inc. (North York, Ontario)
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a

[2H5]Diazepam

N/A

Cerilliant Corp. (Round Rock, TX)

[2H4]Lorazepam

N/A

Cerilliant Corp. (Round Rock, TX)

[2H7]Atenolol

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H3]Albuterol

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H5]Enalaprilat

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H5]Tamoxefen

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H4]Metronidazole

N/A

Toronto Research Chemicals Inc. (North York, Ontario)

[2H5]Clotrimazole

N/A

C/D/N Isotopes Inc. (Pointe-Claire, Quebec)

[2H11]Glyburide

N/A

Toronto Research Chemicals Inc. (North York, Ontario)

[2H6]Fluoxetine

N/A

Cerilliant Corp. (Round Rock, TX)

[2H6]Fenirofibrate

N/A

Toronto Research Chemicals Inc. (North York, Ontario)

[2H5]Timolol

N/A

Toronto Research Chemicals Inc. (North York, Ontario)

Log Kow values were calculated from EPI suite V4.0 KOWWIN V1.68
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After the acclimation period, 84 mosquito fish were exposed to reclaimed water in
a 70-Liter aquarium as exposure group. The exposure experiments consisted of
a 7-day uptake phase with a daily 50% renewal of the reclaimed water.
Approximately eight individual (7-9) mosquito fish and 280 mL of exposure water
were collected for full chemical analysis on 0.2, 1, 2, 3, 5 and 7 days during the
uptake phase. After the uptake phase was completed, the remaining fish were
transferred to another aquarium filled with clean dechlorinated tap water and
allowed to depurate for 14 days. 7-8 individual fish and 280 mL of the depuration
water were collected on 1, 3, 6, 10 and 14 day during the depuration phase.
Meanwhile, the remaining 33 fish were kept in a separate 70-Liter aquarium filled
with clean tap water as control group. 10-13 mosquito fish and 280 mL of water
in the control aquarium were collected on 0 and 7 day of the uptake phase and
14 day of the depuration phase.
Once removed from the aquarium, each fish was rinsed with deionized water to
remove any pharmaceutical residue from its surface and euthanized with liquid
nitrogen according to the approved IACUC plan. All fish collected at the same
sampling event were grouped as one sample and homogenized with a ULTRA
TURRAX IKA T18 stainless steel tissuemiser (Wilmington, NC) set to rotate at
10,000 rpm. The homogenates were stored at –20 °C and thawed at 4 °C for
approximately 10 hours before extraction. All water samples were filtered
immediately after collection and stored in dark at or below 4 °C until they were
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processed. Water extraction was conducted within 7 days of collection to prevent
losses on the basis of biodegradation.
4.2.3 Extraction of fish tissues
Fish homogenates were extracted using a Dionex ASE 200 accelerated solvent
extractor (Dionex Corp., Sunnyvale, CA) fitted with 33 mL stainless steel
extraction cells. 25 grams of Na2SO4 were placed in the extraction cell containing
a glass fiber filter in the outlet side. 1.95-3.16 grams of fish homogenate were
placed on top of the Na2SO4. After adding 200 µL of surrogate solution
containing 100 ng/mL of each surrogate standard, the cell was topped with
another fiber filter, firmly capped and extracted with methylene chloride. The
extraction conditions are as follows: oven temperature 80°C, pressure 1500 psi,
heat for 5 min, 1 static cycle, static time 10 min, flush volume 60% and purge for
120 sec. After each extraction cycle, 30 mL methylene chloride extract was
flushed into a 60-mL glass vial and blown down to approximated 5 mL under
gentle nitrogen stream. The concentrated extract was then quantitatively
transferred to a 10-mL glass test tube and completely dried under gentle nitrogen
stream. The dried extract was reconstituted with 200 μL of methanol:0.1% formic
acid 10:90 (v/v). After 10 min sonication and 1 min of vortex, samples were
transferred and analyzed by LC–MS/MS.
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4.2.4 Extraction of water samples
Immediately after collection, water samples were filtered through 0.5 µm precombusted glass fiber filters (GE Water & Process Technologies, Trevose, PA) to
remove suspended materials. 200 µL of surrogate solution containing 100 ng/mL
of each surrogate standard were added to the samples which were subsequently
extracted as described by Wang et al (Wang and Gardinali 2012). Briefly, Oasis
HLB (3cc/60mg, Waters Corp., Franklin, MA) solid phase extraction cartridges
were conditioned with 3 mL of methanol followed by 3 mL of distilled water. After
the samples had passed through the HLB cartridges, analytes were eluted with 1
mL of methanol. Each methanol eluent was evaporated to dryness under a
gentle stream of nitrogen gas. Dried residues were reconstituted with 200 µL of
methanol:0.1% formic acid 10:90 (v/v). After brief sonication and vortex, the
samples were ready for LC–MS/MS analysis.
4.2.5 LC–MS/MS analysis
Liquid chromatography was performed on a quaternary Thermo Scientific Accela
pump with a Thermo PAL CTC autosampler. A Hypersil GOLD 50 x 2.1 mm, 3
μm particle size and 175 Å pore size column from Thermo Scientific (Bellefonte,
PA) was used for separation. Two sets of mobile phases were used to
accommodate target analytes in both positive and negative ionization modes.
The mobile phases used for positive ionization mode consisted of A, 0.1% formic
acid in water (v/v) and B, 100% methanol. The gradient was (methanol %): 0 min
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3%, 2 min 3%, 8.5 min 97%, 15 min 3% and 17 min 3%. Acetonitrile and water
were used for negative ionization mode. The gradient was (acetonitrile %): 0 min
30%, 1 min 30%, 3 min 80%, 5 min 30% and 7 min 30%. A flow rate of 300
μL/min was maintained for both gradients. The injection volume was set to 10 μL.
All extracts were analyzed by a Thermo TSQ Quantum Access triple quadrupole
(QqQ) mass spectrometry equipped with a heated electrospray ion source (HESI)
operated in both positive and negative modes. Tandem mass spectrometry
detection was performed in selected reaction monitoring (SRM) mode. Collision
energy (CE) and tube lens voltage for each compound were optimized through
direct infusion into mass spectrometer at concentration of 1 μg/mL and at the
flow rate of 15 μL/min. Additional instrumental parameters for the target analytes
in positive mode were optimized as follows: Spray voltage at 4000 V, Capillary
temperature and Vaporizer temperature at 300 °C, Sheath gas (N2) and Aux gas
(N2) at 30 arbitrary units, Ion sweep gas (N2) at 0 arbitrary units, and Scan time at
0.02s. Similarly, the parameters in negative mode were set as follows: Spray
voltage at 5000 V, Capillary temperature and Vaporizer temperature at 155 °C
and 350 °C, respectively, Sheath gas (N2) and Aux gas (N2) at 40 arbitrary units,
Ion sweep gas (N2) at 0 arbitrary units, and Scan time at 0.05s.
4.2.6 QA/QC samples
Laboratory blanks and spiked blank samples were prepared to evaluate
extraction recoveries in both fish and water. Concentrations in water and fish
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samples were determined based on response factors (RFs) of the target analytes
relative to the surrogate internal standards. This approach can be used for most
trace analysis, as it doesn’t require a blank matrix and greatly alleviates the
signal suppression or enhancement arising from matrix effects that can affect the
sensitivity and response of the mass spectrometer (Wang and Gardinali 2012).
Statistically derived method detection limits (MDLs) were used to evaluate the
analytical performance in different matrices as they have been well-described
and deemed appropiate for environmental analysis instead of signal to noise
based limits of detection (LODs) (Ramirez et al. 2007; Ramirez et al. 2009; Wang
and Gardinali 2012). Seven MDL replicate samples were prepared as described
by Wang et al, (Wang and Gardinali 2012) and extracted as described above.
Concentrations below MDLs are reported as “not detected”.
4.2.7 Pharmacokinetics and bioconcentration analysis
A one-compartment first order kinetics model was used to determine the
depuration rate constants (kd) and corresponding half-lives (t1/2) (Barron et al.
1990). Equation (1)-(3), used to solve kd and t1/2 , are as follows:
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Where Cf is the concentration in the organism at time “t” during the depuration
phase, and the constants a and b represent the slope and the intercept of
equation (1), respectively.
The uptake rate constant (ku) during the exposure phase was determined using
the calculated depuration rate constant (kd) as outlined in equation (4) (Barron et
al. 1990):

Where Cf is the concentration in the organism at time “t”, and Cw is the
concentration in water at the same time during the uptake phase.
For comparison, the uptake was also analyzed using the Michaelis-Menten
kinetics model (Hoang et al. 2011).

Where KM is the Michaelis-Menten constant, Cf is the concentration in the fish at
time “t”, and Csat is the concentration in the fish at saturated state (maximal
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concentration). KM/Csat and 1/Csat are the slope and the intercept of equation (5),
respectively. Csat can be determined by plotting 1/Cf over 1/t.
Bioconcentration factors were evaluated by three different approaches. The
steady-state bioconcentration factor was calculated using the concentration
measure in the fish at 7 d of exposure (Cf) and the averaged water concentration
(Cw) from all points taken during the uptake phase.

The ratio of the uptake and depuration rate constants was calculated as the
second bioconcentration factor.

Lastly, a third value for the bioconcentration factor was calculated using Csat as
derived from equation (5) using the averaged concentrations in water during the
whole exposure time.

4.3 Results and Discussions
No significant changes in water quality parameters or fish mortalities were
observed throughout the study. Temperature was maintained at 26.1 ± 0.7 °C,
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dissolved oxygen was at 5.5 ± 0.6 mg/L, and pH was at 8.6 ± 0.2. No free
chlorine was detected in any of the water samples.
As shown in Table 4.2, a total of 26 pharmaceuticals ranging from 21.3 ng/L for
fluoxetine to 8638 ng/L for caffeine were detected in the reclaimed water used in
the exposure experiment. The relative standard deviation for exposure
concentrations was less than 30.4 % in most cases, with exceptions for
sulfamethoxazole at 48.2 %, and for naproxen at 52.4%, respectively. No target
analytes were detected in control water or control fish at levels above the
corresponding MDLs.
Table 4.2 Pharmaceuticals detected in exposure reclaimed
water

Ionization
mode

Concentration in
Compound

RSD (%)

reclaimed water
(ng/L)

(n=7)

Positive

Metronidazole

66.3 ± 11.1

16.8

Positive

Sotalol

594 ± 23.1

3.9

Positive

Salbutamol

68.8 ± 11.3

16.5

Positive

Atenolol

4605 ± 405

8.8

Positive

Codeine

201 ± 35.6

17.7

Positive

Trimethoprim

816 ± 109

13.3
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Positive

Caffeine

8638 ± 937

10.9

Positive

Nadolol

161 ± 35.3

22.0

Positive

Sulfamethoxazole

1152 ± 556

48.2

Positive

Metoprolol

196 ± 21.1

10.7

Positive

Propranolol

148 ± 33.2

22.4

Positive

Betaxolol

523 ± 34.1

6.5

Positive

Diphenhydramine

5218 ± 1350

25.9

Positive

Diltiazem

144 ± 43.7

30.4

Positive

Carbamazepine

1229 ± 112

9.1

Positive

Erythromycin

288 ± 45.6

15.8

Positive

Fluoxetine

21.3 ± 3.29

15.5

Positive

Lorazepam

117 ± 13.4

11.4

Positive

Tamoxifen

33.5 ± 1.6

4.7

Positive

Glibenclamide

115 ± 14.8

12.8

Negative

Phenobarbital

55.7 ± 12.5

22.5

Negative

Butalbital

126 ± 18.5

14.7

Negative

Naproxen

73.0 ± 38.2

52.4
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Negative

Diclofenac

958 ± 106

11.1

Negative

Ibuprofen

331 ± 35.8

10.8

Negative

Gemfibrozil

2272 ± 605

26.6

The observed concentrations for trimethoprim, caffeine, sulfamethoxazole,
diphenhydramine, diltiazem, carbamazepine, erythromycin, and fluoxetine in
reclaimed water were higher than those in previous reports (Wang and Gardinali
2012; Wang and Gardinali 2012), in which reclaimed water was directly drawn
from irrigational sprinklers. The mechanism for the loss in the reclaimed water
drawn from sprinklers is unclear but is likely the results of different input sources.
Therefore, the reclaimed water collected directly from the source outlet with
higher concentrations was used here in order to maximize the chances of
detecting more compounds that might be bioconcentrated by fish. Among the 26
pharmaceuticals detected in reclaimed water, 5 pharmaceuticals including
caffeine, diphenhydramine, diltiazem, carbamazepine, and ibuprofen were
observed in mosquito fish as early as 5 h from the start of the exposure to
reclaimed water. Uptake and depuration rate constants along with BCFs are
summarized in Table 4.3 and shown in Figure 4.1. One-compartment first order
and Michaelis-Menten kinetics models were fitted to the uptake and depuration
curves. In general, both models fitted all uptake curves fairly well, while
Michaelis-Menten kinetics model fitted the uptake curves better for caffeine
(R2=0.9980), diphenhydramine (R2=0.9521), and carbamazepine (R2=0.9849),
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whereas one-compartment first order model fitted the uptake curve better for
diltiazem (R2=0.9871) and ibuprofen (R2=0.9812). All depuration curves
appeared to follow first order elimination.
Table 4.3 Uptake and depuration rate constants, half-lives and BCFs for
selected pharmaceuticals in mosquito fish (Gambusia holbrooki)

Compound

ku (mL g-1 h-1)

kd (h-1)

t1/2 (h)

BCFa

BCFb

BCFc

Caffeine

0.0011

0.0049

141

2.0

0.23

2.0

Diphenhydramine 0.21

0.020

34

16

10

15

Diltiazem

0.033

0.0059

117

16

5.6

16

Carbamazepine

0.0085

0.0098

71

1.4

0.87

1.4

Ibuprofen

0.64

0.022

32

28

29

27

4.3.1 Uptake and depuration kinetics
The uptake of caffeine by mosquito fish was very rapid as the internal
concentration reached the plateau and remained approximately constant after 5
h of the exposure. Similar uptake behavior was also documented in Nile tilapia
(Oreochromis niloticus) (Gomez-Martinez 2011). However, the depuration rate of
caffeine in mosquito fish was much slower than that found in Nile tilapia, in which
caffeine had a half-live of 4.95 h (Gomez-Martinez 2011) compared to the 141 h
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for mosquito fish calculated in this study. The results indicate that caffeine would
be uptaken by mosquito fish and Nile tilapia at relatively the same rate but
remain in mosquito fish for a longer time and therefore, pose higher risks to
mosquito fish than it does to Nile tilapia. For carbamazepine, the uptake rate
constant (0.0085 mL g-1 h-1 or 0.20 L kg-1 day-1) and depuration rate constant
(0.0098 mL g-1 h-1 or 0.24 L kg-1 day-1) in mosquito fish were similar to those
reported in water boatman (Notonecta glauca) which were calculated at 0.29 L
kg-1 day-1 and 1.2 L kg-1 day-1, respectively (Meredith-Williams et al. 2012). As a
result, the rate constant-based BCF of 0.87 in mosquito fish was slightly higher
than that of 0.24 in water boatman (Meredith-Williams et al. 2012). In contrast, a
higher BCF for carbamazepine in freshwater shrimp (Gammarus pulex) was
calculated at 7.1 in the same study (Meredith-Williams et al. 2012), and the value
was 30 times and 8 times higher than that in water boatman and mosquito fish,
respectively. The phenomenon that BCFs are organism size related has been
previously discussed (Hendriks et al. 2001). The findings by Meredith-Williams et
al. (Meredith-Williams et al. 2012) indicated that BCFs were indeed reduced as
the organism size increased. Among the 5 pharmaceuticals detected in mosquito
fish, diphenhydramine had the highest internal concentration of 82 ng/g that was
reached after 77 h of the exposure to reclaimed water. During the depuration,
diphenhydramine was quickly eliminated with the second shortest half live of 34 h.
Similarly, a gradual uptake followed by a rapid depuration was observed for
ibuprofen resulting the shortest half live (32 h) and the highest BCF among the
five pharmaceuticals. Diltiazem followed a similar uptake curve as observed for
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carbamazepine but the half-life (117 h) was longer than that of carbamazepine
(71 h). Published data on the pharmacokinetics of diphenhydramine, diltiazem,
and ibuprofen in aquatic organisms are limited, but data are available on BCFs of
these compounds which will be compared below.
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Figure 4.1 Uptake and depuration curves for mosquito fish (Gambusia holbrooki)
exposed to reclaimed water: the dotted lines represent for the Michaelis-Menten
curve fit and the solid lines represent for the first order curve fit
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4.3.2 Bioconcentration factors
In Table 4.3, BCFb ranged from 0.23 to 29 and increased in the order of caffeine
< carbamazepine < diltiazem < diphenhydramine < Ibuprofen. BCFa and BCFc
ranged from 2.0 to 28, and increased in the order of carbamazepine < caffeine <
diltiazem

<

diphenhydramine

<

Ibuprofen.

BCFs

found

for

caffeine,

diphenhydramine, and carbamazepine in mosquito fish were respectively lower
than those reported from the previous study for natural exposure in the pond
influenced by irrigation with reclaimed water (29 for caffeine, 821 for
diphenhydramine, and 108 for carbamazepine) (Wang and Gardinali 2012). The
lower BCFs in the laboratory experiment with full strength reclaimed water could
possibly be related to the availability of additional dietary routes for the mosquito
fish in natural settings (Blanco et al. 2004). In addition, the pond system may
contain higher concentration of dissolved organic carbon (DOC) that has been
shown to significantly enhance the BCFs of organic pollutants (Pickhardt et al.
2006). Despite the known effects of acid base equilibrium on BCFs for ionizable
compounds (Nakamura et al. 2008), the pH was not believed to have significant
effects on the BCFs in this study because the pH of 8.6 in reclaimed water was
similar to that in the fresh water pond (Wang and Gardinali 2012). BCFs
calculated for carbamazepine, diltiazem, and ibuprofen in this study were in
reasonably good agreement (within one order of magnitude) with plasma BCFs
reported in the rainbow trout (Oncorhynchus mykiss) after exposed to treated
sewage effluents (Fick et al. 2010). BCFs for carbamazepine in mosquito fish
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(ranging from 0.87 to 1.4) were also in agreement with tissue BCF of 0.52 in
rainbow

trout

(Zhang

et

al.

2010).

Ibuprofen

however,

appeared

to

bioconcentrate less in rainbow trout (BCF of 1.5) (Zhang et al. 2010) than it did in
mosquito fish (BCF of 29) in this study. Upon reviewing the literature (Brooks et
al. 2005; Chu and Metcalfe 2007; Nakamura et al. 2008; Paterson and Metcalfe
2008), fluoxetine, one of the most widely found pharmaceuticals in fish was not
detected in any of the fish samples even though it was detected in the exposure
reclaimed water at a concentration of 21.3 ± 3.29 ng/L in this study. This is not
surprising because the concentration of fluoxetine in fish would be slightly above
the MDL of 1.2 ng/g (Wang and Gardinali 2012) even if it bioconcentrated based
on the highest BCF value reported at 80 (Paterson and Metcalfe 2008).
Lastly, when constructing graphs (Figure 4.2) of calculated BCFs vs Log Kow,
excellent positive relationships were observed for all compounds, with the
exception of caffeine that had to be excluded from the plots. This behavior is
consistent with previously proposed predictive models (Gossett et al. 1983). The
abnormal behavior of caffeine was probably on the basis of its extreme Log Kow
value of –0.07 (Stackelberg et al. 2007), thus caffeine most likely reached
equilibrium between water and fish tissue instead of bioconcentration.

76

77

Figure 4.2 Correlations between bioconcentration factors and Log Kow (BCFa:
based on steady state concentrations, BCFb: based on rate constants, and BCFc:
based on saturation state concentrations)
4.4 Conclusions
This study described the pharmacokinetics and bioconcentration of 5
pharmaceuticals in mosquito fish under the “worst case” exposure scenario. The
results showed that some pharmaceuticals such as diphenhydramine could be
accumulated in fish up to 82 ng/g while some pharmaceuticals such as caffeine
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will rather equilibrate with the surrounding waters and would persist for a period
of several days. The study also showed that a number of other compounds
detected in rather high concentrations (e.g. diclofenac and gemfibrozil) did not
accumulate in fish despite having moderately high Log Kow values implying that
other mechanisms may have played a role in keeping them in solution. Because
many aquatic species have similar physiological receptors to those originally
targeted for pharmacological effects in humans (Owen et al. 2007; Gunnarsson
et al. 2008), non-target species under chronic exposure may show potential
adverse effects (Berninger and Brooks 2010; Fick et al. 2010). Therefore, future
studies focused on biotransformation and metabolism in fish particularly targeting
compounds with long persistence would provide useful information for predicting
toxic effects in fish.
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CHAPTER 5
Identification of phase II pharmaceutical metabolites in reclaimed water
using high resolution benchtop Orbitrap mass spectrometry
(Manuscript ready for submission to Analytical Chemistry, 2013)
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5.1 Introduction
Pharmaceutically active compounds are now well-acknowledged pollutants in the
environment, especially in surface water and wastewater. They are released into
the environment largely through the discharge of wastewater treatment plants
(WWTPs) as a result of excretion and metabolism by humans and animals, and
additionally disposal of unused or expired drugs (Daughton and Ternes 1999;
Miao and Metcalfe 2003; Vanderford et al. 2003). Many studies have
demonstrated that pharmaceuticals may pose adverse effects to wildlife and
humans (drinking water) under chronic long-term exposure despite the relatively
low concentrations in the environment (Vanderford et al. 2003; Brooks et al.
2005).

Therefore,

it

is

not

surprising

that

much

attention

regarding

pharmaceuticals in the environment has been drawn on the basis of ecological
concerns and public health.
The presence of pharmaceutically active compounds in the environment is
assessed largely by measuring the parent drugs (i.e., carbamazepine and
fluoxetine) and to a lesser extent transformation products (i.e., 10,11-dihydro10,11-dihydroxycarbamazepine, the major metabolite of carbamazepine, and
norfluoxetine, the major metabolite of fluoxetine) (Miao and Metcalfe 2003;
Brooks et al. 2005; Miao et al. 2005; Chu and Metcalfe 2007). Parent drugs can
be excreted as the unchanged form (Miao et al. 2005) whereas transformation
products can be formed as metabolites by undergoing chemical or biochemical
transformations (Gobel et al. 2004) or as photodegradation products by exposure
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to sunlight (Bonvin et al. 2012). Parent drugs can undergo a broad range of
reactions during metabolism which can be categorized into two phases (Murphy
2001). Phase I reactions including oxidation, reduction and hydrolysis convert the
parent drug into a more polar metabolite by adding or revealing functional groups
such as –OH, –SH, –NH2 and –COOH, etc.. The mechanism involves a variety of
enzymes such as cytochrome P450 oxidase and NADPH-cytochrome P450
reductase introducing reactive and polar groups into their substrates (Lu et al.
1969; Guengerich and Johnson 1997; Danielson 2002; Gu et al. 2003). The
conversions including benzene to phenol (Schultzen and Naunyn 1867) and
benzaldehyde to benzoic acid (Wohler and Frerichs 1848) were among the very
first pieces of evidence indicating the ability of the body to oxidize xenobiotic
compounds. Phase II metabolism is a conjugation reaction catalyzed by a large
group of broad-specificity transferases (Williams 1947). Parent drugs and active
metabolites are often conjugated with charged species such as glutathione
(GSH), sulfate, glycine, or glucuronic acid to be detoxified (Chen et al. 2005;
Berthiller et al. 2006; Holcapek et al. 2008). Current research is focusing heavily
on unchanged parent drugs (Celiz et al. 2009). However, it is important to realize
that the exposure to metabolites may have hazardous effects similar to those of
the parent drugs (Bedner and MacCrehan 2006).
Numerous analytical instruments have been applied to investigate the
occurrence of parent drugs in a variety of environmental matrices (Vanderford et
al. 2003; Davis et al. 2006; Kwon and Armbrust 2006; Ramirez et al. 2007;

82

Schultz et al. 2010; Wang and Gardinali 2012). Liquid chromatography coupled
with triple quadrupole (QqQ) and to a lesser extend ion trap mass spectrometry
is undoubtedly the most used approach in such targeted analysis. With the aids
of high sensitivity and selectivity that tandem mass spectrometry offers when
encountering complex matrices, most parent drugs can be detected and
quantified at lower ng/L or ppt level (Miao and Metcalfe 2003; Miao et al. 2005;
Lajeunesse et al. 2008; Wang and Gardinali 2012). In contrast, little attention has
been paid to the identification, let alone quantification, of pharmaceutical
metabolites (Celiz et al. 2009) because there could be numerous metabolites
from one parent drug and it is also practically impossible to purchase or
synthesize standards for all the metabolites. An addition consideration is the
economical unsoundness of purchasing the standards for all metabolites. As a
result, current targeted analysis of metabolites using tandem mass spectrometry
is only limited to pharmaceuticals whose metabolites are well “known” from
clinical data and standards for the metabolites are readily available to confirm the
identity (Miao and Metcalfe 2003; Gobel et al. 2004; Miao et al. 2005). However,
the increasing number of studies reporting the presence of metabolites in the
environment underlines the urge to include non-target or unknown metabolites as
an important part of routine analysis of pharmaceuticals. For instance, several
LC-MS methods have been developed to determine carbamazepine, one of the
most frequently detected pharmaceuticals in WWTP effluents and surface water,
along with its major phase I metabolites in aqueous samples (Miao and Metcalfe
2003;

Miao

et

al.

2005).

Interestingly,
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metabolite

10,11-dihydro-10,11-

dihydroxycarbamazepine was found to be the dominant analyte which had a
concentration 3 to 4 times higher than that of carbamazepine in wastewater
(Miao and Metcalfe 2003). A significant increase of the parent drug was also
observed in the treated wastewater effluent relative to concentrations in the
untreated wastewater influent, suggesting that some phase II metabolites could
have been transformed to the free form by cleavage of the conjugates during the
treatment. The increase of the parent drug is likely related to the fact that
hydroxylated metabolites of carbamazepine occur primarily in conjugated forms
such as glucuronidation in body fluids (Miao et al. 2005). A more recent study
provided the first evidence that phase II metabolites of sulfamethoxazole existed
and could be back-transformed to its parent drug under abiotic conditions,
indicating that these phase II metabolites may survive wastewater treatment and
serve as an additional environmental source of sulfamethoxazole (Bonvin et al.
2012). Therefore, it is increasingly important to include phase II metabolites when
assessing the occurrence, fate and transport of pharmaceuticals in the
environment.
In recent years, high resolution mass spectrometry including time of flight (TOF)
and Orbitrap has become a powerful tool at identifying “unknown” metabolites in
both metabolomics and environmental studies (Lim et al. 2007; Ferrer and
Thurman 2010; Calza et al. 2012; Thurman and Ferrer 2012). Operated at a
resolving power > 40,000, mass accuracy < 5 ppm is normally achievable on
modern TOF instruments allowing positive identification based on accurate mass
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measurements. Difficulties associated with using TOF instruments are the limited
dynamic range and the dependence on lock mass or internal calibration to
maintain high mass accuracy (Petrovic et al. 2006; Ibanez et al. 2012). In
contrast, external calibration can be used for Orbitrap instruments to obtain
excellent mass accuracy (<3 ppm) resulting a simplified operational protocol (Lim
et al. 2007). In addition, Orbitrap instruments offer better dynamic range and
sensitivity close to those of many triple quadrupole instruments. The features that
Orbitrap offers are especially important for environmental analysis when the
concentrations are not sufficiently high compared to those in metabolic or
pharmacokinetic studies (Peterman et al. 2006).
The objectives in this study were to identify phase II metabolites in reclaimed
water using a Q Exactive Orbitrap mass spectrometer based on accurate mass
measurements combined with characteristic ions from MS/MS data dependent
scans, and to determine the concentrations of identified phase II metabolites
relative to their parent drugs in reclaimed water.
5.2 Experimental
5.2.1 Chemicals and Standards
Reference standards of pharmaceuticals, two metabolites (norfluxetine and Odesmethyltramadol) and isotopically labeled standards were purchased from
Sigma-Aldrich (Milwaukee, WI), MP Biomedicals, LLC. (Santa Ana, CA),
Cerilliant Corp. (Round Rock, TX), American Radiolabeled Chemicals,Inc. (St
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Louis, MO), Toronto Research Chemicals Inc. (North York, Ontario), ACROS
organics (Morris Plains, NJ), C/D/N Isotopes Inc. (Pointe-Claire, Quebec) and
Cambridge Isotopes Lab. Inc. (Andover, MA). Details of the sources of standards
were also shown in Table 4.1. All standards presented purity higher than 95%.
Pierce LTQ Velos ESI positive ion and negative ion calibration solutions (Thermo
Scientific, Rockford, IL) for Q Exactive orbitrap mass spectrometer were provided
by Thermo Scientific (Rockford, IL). LC-MS grade methanol, water and formic
acid were purchased from Fisher Scientific (Bridgewater, NJ). The 0.1% formic
acid used as mobile phase was prepared daily. All stock solutions (100 ppm) and
working solutions were made in methanol and stored in the dark at –20 °C.
5.2.2 Sample Collection
During a period of one month, reclaimed water (500 mL) was directly drawn from
the reclaimed water outlet at Florida International University Biscayne Bay
Campus (North Miami, FL). Polyethylene terephthalate bottles (500 mL) were
used to collect water samples and rinsed with the sampling water three times
before the samples were taken. Water samples were filtered and stored in dark
at or below 4 °C until processed. Head space was minimized by filling the bottles
completely. Water extraction was conducted within 7 days of collection to prevent
changes associated with biodegradation.
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5.2.3 Sample Extraction
To remove suspended materials, water samples were filtered through 0.5 µm
pre-combusted glass fiber filters (GE Water & Process Technologies, Trevose,
PA) within 24 h after collection. Each water sample was extracted with an Oasis
HLB (3 cc/60 mg, Waters Corp., Franklin, MA) cartridge coupled in tandem to a
Sep-Pak tC18 Plus cartridge (900 mg, Waters Corp., Franklin, MA). The
combination of two different sorbent materials was used to ensure high
recoveries of the metabolites (Eichhorn et al. 2005). Both cartridges were
conditioned together with 5 mL of methanol followed by 5 mL of distilled water.
Solid phase extraction was performed on an ALLTECH 12-port vacuum manifold
(Deerfield, IL). After the samples had passed through the cartridges, the analytes
were eluted with 3 mL of methanol. The methanol eluent was evaporated to
dryness under a gentle stream of purified nitrogen gas. Dried residues were
reconstituted with 200 µL of methanol:0.1% formic acid 50:50 (v/v). After brief
sonication and vortex, the samples were ready for LC-MS analysis.
5.2.4 Liquid Chromatography and Q Exactive Mass spectrometry
Liquid chromatography was performed on a quaternary Thermo Scientific Accela
pump with a Thermo PAL CTC autosampler. A Hypersil GOLD 50 x 2.1 mm, 3
μm particle size and 175 Å pore size column from Thermo Scientific (Bellefonte,
PA) was used for separation. Two sets of mobile phases were used for both
positive and negative ionization modes. The mobile phases used for positive

87

ionization mode consisted of A, 0.1% formic acid in water (v/v) and B, 100%
acetonitrile. Acetonitrile and water were used for negative ionization mode. The
gradient remained the same for both ionization modes, which was (acetonitrile
%): 0 min 3%, 2 min 3%, 8.5 min 97%, 15 min 3% and 17 min 3%. A flow rate of
300 μL/min was maintained for both gradients. The injection volume was set to
10 μL.
All extracts were analyzed by a Q Exactive Orbitrap mass spectrometer (Thermo
Scientific, San Jose, CA) equipped with a heated electrospray ion source (HESIII) operated in both positive and negative modes. As a part of routine
maintenance, the instrument was calibrated weekly using Pierce LTQ Velos ESI
Positive Ion and Negative Ion Calibration Solutions (Thermo Scientific, Rockford,
IL) for positive and negative modes, respectively. Mass accuracy less than 0.6
ppm was always achieved from the external calibration that was performed prior
to analysis or every 24 hours. Ultra-pure nitrogen and argon were used as ion
source gas and collision gas, respectively. Mass spectrometry parameters in
positive mode were set as follows: Sheath gas, Aux gas and Sweep gas were at
35, 35 and 5 arbitrary units, respectively. Similarly, the parameters in negative
mode were set as follows: Sheath gas, Aux gas and Sweep gas were at 40, 20
and 5 arbitrary units, respectively. The following parameters remained the same
for both positive and negative modes: Spray voltage was at 4 kV. Capillary
temperature and Vaporizer temperature were at 300 °C. The data-dependent
scan cycle included a full scan operated at a resolving power of 70,000 with a
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scan range from 80-1000 m/z and three corresponding data-dependent MS/MS
scans acquired at resolving power of 35,000. The three most abundant precursor
ions triggered data-dependent scanning and were subsequently injected to the
C-trap to be fragmented. Isolation window for MS/MS scanning was set to 2 m/z.
Normalized collision energy (NCE) was set to 35 with stepped NCE of 25%.
5.2.5 Data Interpretation
The calculation of exact masses from elemental compositions was carried out
using MetWorks 1.3 (Thermo Scientific, San Jose, CA). High resolution extracted
ion chromatograms (XICs) of the parent pharmaceutical and its potential phase II
metabolites were obtained by processing the full scan data using MetWorks with
a 5 ppm mass tolerance. Data-dependent spectra of the positively identified
compounds were further investigated by Mass Frontier 7.0 (Thermo Scientific,
San Jose, CA) using the Fragment Ion Search (FISh) feature, in which theoretical
spectra generated from chemical structures were compared with those observed
from the experiment. Similarities between the theoretical and observed spectra,
along with isotope patterns, even electron species and rings plus double bonds
(RDB) values were considered to aid the assignment of metabolite identification.
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5.3 Results and discussions
5.3.1 Performance of Q Exactive Orbitrap

Table 5.1 shows the selected pharmaceuticals routinely monitored in reclaimed
water as described in previous studies. The performance of accurate mass
measurements in external calibration mode was investigated by injecting 10 μL of
the mixture of all parent pharmaceutical standards at 200 ng/mL immediately
after calibration and at the end of each sequence up to 16 h post-calibration. The
observed accurate masses were systematically lower than exact masses for the
majority of compounds, but the mass accuracy never exceeded 2.9 ppm except
for naproxen which was calculated at -3.9 ppm (Table 5.1). Mass accuracy was
also evaluated for the standards injected at the end of each sequence. Mass
accuracy of 4 ppm or better was always achieved for all compounds after up to
16 h post-calibration (data not shown). The values for mass accuracy were better
than those obtained from most time-of-flight mass spectrometers in internal
calibration mode (Petrovic et al. 2006; Ferrer and Thurman 2010; Thurman and
Ferrer 2012).
Table 5.1 Elemental compositions, exact masses, observed accurate
masses, and mass accuracy of selected parent pharmaceuticals

Name
Atenolol

Elemental

Exact

Composition

Mass (m/z)

C14H22N2O3

267.1703
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Observed

Mass

Accurate

Accuracy

Mass (m/z)

(ppm)

267.1696

-2.6

Atorvastatin

C33H35FN2O5

559.2603

559.2593

-1.8

C18H29NO3

308.2220

308.2213

-2.3

C19H20ClNO4

360.1008

360.1011

0.8

C11H16N2O3

223.1088

223.1085

-1.3

Caffeine

C8H10N4O2

195.0877

195.0873

-2.1

Carazolol

C18H22N2O2

299.1754

299.1747

-2.3

Carbamazepine

C15H12N2O

237.1022

237.1017

-2.1

Clenbuterol

C12H18Cl2N2O

277.0869

277.0863

-2.2

Clotrimazole

C22H17ClN2

345.1153

345.1146

-2.0

Codeine

C18H21NO3

300.1594

300.1588

-2.0

Diazepam

C16H13ClN2O

285.0789

285.0785

-1.4

Diclofenac a

C14H11Cl2NO2

294.0094

294.0097

1.0

Diltiazem

C22H26N2O4S

415.1686

415.1677

-2.2

Diphenhydramine

C17H21NO

256.1696

256.1690

-2.3

Enalapril

C20H28N2O5

377.2071

377.2062

-2.4

Enalaprilat

C18H24N2O5

349.1758

349.1751

-2.0

Erythromycin

C37H65NO12

716.4580

716.4562

-2.5

Fenofibrate

C20H21ClO4

361.1201

361.1191

-2.8

Fluoxetine

C17H18F3NO

310.1413

310.1409

-1.3

Furosemide a

C12H11ClN2O5S

329.0004

329.0009

1.5

Gemfibrozil a

C15H22O3

249.1496

249.1495

-0.4

Glibenclamide

C23H28ClN3O5S

494.1511

494.1503

-1.6

C13H18O2

205.1234

205.1228

-2.9

Ketoprofen a

C16H14O3

253.0870

253.0873

1.2

Lincomycin

C18H34N2O6S

407.2210

407.2202

-2.0

C15H10Cl2N2O2

321.0192

321.0186

-1.9

C15H15NO2

240.1030

240.1030

0.0

Metoprolol

C15H25NO3

268.1907

268.1902

-1.9

Metronidazole

C6H9N3O3

172.0717

172.0713

-2.3

Mevastatin

C23H34O5

391.2479

391.2471

-2.0

Nadolol

C17H27NO4

310.2013

310.2005

-2.6

Naproxen a

C14H14O3

229.0870

229.0861

-3.9

Norfluoxetine

C16H16F3NO

296.1257

296.1250

-2.4

Betaxolol
Bezafibrate
Butalbital

Ibuprofen

a

a

a

Lorazepam
Mefenamic acid

a
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Paroxetine

C19H20FNO3

330.1500

330.1491

-2.7

C11H18N2O3

225.1245

225.1240

-2.2

C12H12N2O3

231.0775

231.0771

-1.7

Pindolol

C14H20N2O2

249.1598

249.1593

-2.0

Pravastatin

C23H36O7

447.2353

447.2348

-1.1

Propranolol

C16H21NO2

260.1645

260.1639

-2.3

Salbutamol

C13H21NO3

240.1594

240.1591

-1.2

Sertraline

C17H17Cl2N

306.0811

306.0807

-1.3

Sotalol

C12H20N2O3S

273.1267

273.1261

-2.2

Sulfamethoxazole

C10H11N3O3S

254.0594

254.0589

-2.0

Tamoxifen

C26H29NO

372.2322

372.2315

-1.9

Timolol

C13H24N4O3S

317.1642

317.1640

-0.6

Trimethoprim

C14H18N4O3

291.1452

291.1445

-2.4

Pentobarbital a
Phenobarbital

a

a

Compounds detected in negative mode [M–H]–

5.3.2 Tentative Identification of Phase II metabolites based on Accurate
Mass
Because this study focuses on phase II metabolites, the identification procedure
will only be discussed for the cases when both parent drug and at least one of its
metabolites are present together. On the basis of the fact that most phase II
metabolites are more water soluble than the corresponding parent drugs (Ferrer
and Thurman 2010), with the exception of acetylation (Gobel et al. 2004), an
earlier retention time of a metabolite is a positive indication when tentatively
identifying metabolites based on accurate mass. Moreover, it is difficult to be
certain if the observed peak is a metabolite or another isomer without knowing
the chromatographic behavior of the parent drug (Ferrer and Thurman 2012).
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Peaks from full scan chromatograms that show intensities lower than 1 x 105
counts will not be considered because the intensity would not be high enough to
trigger a data-dependent MS/MS scan, which is essential for structure
elucidation.
Upon inputting the elemental composition and polarity of each selected
pharmaceutical into MetWorks, XICs for the parent drug along with its most
commonly found phase II metabolites are created based on the exact masses of
modifications using a mass tolerance at 5 ppm. These calculations were shown
in Table 5.2.

Table 5.2 Monitored phase II modifications and exact
masses of the modifications to parent pharmaceuticals
Exact Mass of

Phase II Modification

Modification

Glucuronidation

+176.0321

Glutathione conjugation

+307.0838

Sulfation

+79.9568

Acetylation

+42.0106

Glycine conjugaion

+57.0215

Cysteine conjuation

+103.0092

Taurine conjugation

+107.0041

S-cysteine conjugation

+119.0041

N-acetylcysteine conjugation

+161.0147

Hydroxylation and Glucuronidation

+192.0270

Decarboxylation and Glucuronidation

+148.0372
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Hydroxylation and Sulfation

+95.9517

De-ethylation + Glucuronidation

+148.0008

De-methylation + Glucuronidation

+162.0164

Epoxidation + S-GSH conjugation

+323.0787

Desaturation + S-GSH conjugation

+305.0682

A detailed examination of the XICs for all potential metabolites in reclaimed water
samples

revealed

that

sulfamethoxazole

glucuronide

and

acetyl-

sulfamethoxazole, two phase II metabolites of sulfamethoxazole, appeared at
retention times of 5.38 min and 5.56 min, respectively (Figure 5.1). Meanwhile, a
peak at 5.46 min was also observed for sulfamethoxazole as shown in Figure
5.1. The retentive behaviors of these compounds were in good agreement with
those reported in literature (Gobel et al. 2004), in which sulfamethoxazole eluted
later than sulfamethoxazole glucuronide but earlier than acetyl-sulfamethoxazole.
The accurate mass of sulfamethoxazole was observed at m/z 254.0590, which is
-1.6 ppm from its exact mass at m/z 254.0594. For verification purposes, the
mixture containing all parent pharmaceutical standards at 200 ng/mL was
injected onto the column, and sulfamethoxazole standard was eluted at the same
retention time with the same measured accurate mass (m/z 254.0590).
Therefore, sulfamethoxazole can be identified in reclaimed water samples based
on retention time and its elemental composition (less than 5 ppm). Additional
confirmation was done by comparing MS/MS spectra with those obtained from
sulfamethoxazole standard (Figure 5.2).
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Figure 5.1 LC-Q Exactive Orbitrap extracted ion chromatograms (XICs) of
sulfamethoxazole (m/z 254.0594), sulfamethoxazole glucuronide (m/z 430.0915)
and acetyl-sulfamethoxazole (m/z 296.0700) in a reclaimed water sample; mass
tolerance was set to 5 ppm for all compounds

The accurate masses for both metabolites were measured at m/z 430.0916 and
m/z 296.0695 (mass accuracy less than 1.7 ppm from their exact masses),
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respectively, which correspond to the addition of glucuronic acid (176 Da) and
acetyl group (42 Da) to sulfamethoxazole. These metabolites can only be
tentatively identified at this point because standards and their detailed
fragmentation patterns are needed to ensure their identities. Unfortunately, unlike
metabolic studies where there are metabolite-free blank samples to compare
with, and more importantly, there are much fewer compounds to deal with,
environmental studies monitor dozens, sometimes hundreds of compounds
which make purchasing or synthesizing metabolite standards for all compounds
unrealistic and economically unsound. An alternative that could be applied here
when metabolite standards are not readily available is to compare the similarities
of fragmentation patterns between parent drug and its phase II metabolites as
they share the “back bone” in their molecular structures (Lim et al. 2007;
Thurman and Ferrer 2012). Moreover, combining high resolution accurate mass
measurements and tandem mass spectrometry increases the confidence of the
proposed structures of product ions. The availability of chemical formulas for all
precursor and product ions, irrespective of relative ion abundance, generated
from high resolution data-dependent spectra can also accelerate the structure
elucidation of metabolites (Ferrer and Thurman 2010; Thurman and Ferrer 2012).
Therefore,

data-dependent

sulfamethoxazole

spectra

glucuronide

and

showing

fragmentation

acetyl-sulfamethoxaozle

patterns
were

further

investigated against that obtained for sulfamethoxazole using Mass Frontier.
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5.3.3 Identification of Acetyl-sulfamethoxazole and Sulfamethoxazole
Glucuronide
The high resolution data-dependent MS/MS spectrum of m/z 254.0590 at
retention time 5.46 min in the reclaimed water extract was shown In Figure 5.2B,
which was nearly identical with that observed for sulfamethoxazole standard
(Figure 5.2A). The two most abundant fragment ions at 156 Da and 108 Da were
in good agreement with those reported in previous studies (Sacher et al. 2001;
Vanderford et al. 2003). The structures of all major fragments were predicted by
Mass Frontier on the basis of the fragmentation rules built into the software and
labeled in Figure 5.2A and 5.2B. All the labeled fragment ions in Figure 5.2B
matched within 1.8 ppm and satisfied the ion fragments predicted by Mass
Frontier. The proposed fragmentation pathway is also shown in Figure 5.3A.
Therefore, these high resolution MS/MS data clearly showed that the ion m/z
254.0590 was sulfamethoxazole and once again confirmed the presence of
sulfamethoxazole in the reclaimed water sample.
Figure 5.2C shows the MS/MS spectrum of m/z 296.0695 at retention time 5.56
min, which corresponds within -1.7 ppm to the exact mass of acetylsulfamethoxazole. The four most intense fragment ions at 65 Da, 108 Da, 134 Da
and 198 Da were consistent with those observed by Gobel et al (Gobel et al.
2004) using unit resolution triple quadruple mass spectrometer. All labeled
fragment ions in Figure 5.2C matched within 4.9 ppm and satisfied the ion
fragments predicted by Mass Frontier. The proposed fragmentation pathway of
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acetyl-sulfamethoxazole was also described in Figure 5.3B for the first time.
Fragment ions at 134 Da, 150 Da, 198 Da and 236 Da containing acetyl groups
clearly showed that these ions were generated from the acetylation of
sulfamethoxazole suggesting that the m/z 296.0695 was indeed acetylsulfamethoxazole.
Similarly, Figure 5.2D shows the MS/MS spectrum of m/z 430.0916 at retention
time 5.38 min, which corresponds within 0.2 ppm to the exact mass of
sulmathoxoazole glucuronide. The m/z 430.0916 ion lost 176.0330 to form m/z
254.0586, which is a loss within 4.5 ppm for the glucuronic acid. The ion m/z
254.0586, which is -3.1 ppm from the exact mass of sulfamethoxazole, further
fragmented to give two important ions at m/z 108.0445 (1.2 ppm mass accuracy)
and m/z 156.0110 (-2.8 ppm mass accuracy), which were also observed as the
two most abundant fragment ions for sulfamethxoazole standard (Figure 5.2A).
These

two

ions

together

indicated

that

m/z

254.0586

was

indeed

sulfamethoxazole formed on the basis of the de-conjugation of glucuronic acid.
The fragmentation pathway of the glucuronide conjugate was shown in Figure
5.3C. Thus, the evidence is strong that the ion m/z 430.0916 is sulfamethoxazole
glucuronide.
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Figure 5.2 High resolution data-dependent MS/MS spectra and major fragments for A: sulfamethoxazole standard, B:
sulfamethoxazole in reclaimed water, C: acetyl-sulfamethoxazole in reclaimed water, and D: sulfamethoxazole
glucuronide in reclaimed water
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Figure 5.3 Proposed fragmentation pathways for A: sulfamethoxazole, B: acetylsulfamethoxazole, and C: sulfamethoxazole glucuronide
5.3.4 Determination of Sulfamethoxazole and Its Metabolites in Reclaimed
Water
Collected reclaimed water samples were spiked with sulfamethoxazole-d4 (exact
mass at m/z 258.0845) as surrogate internal standard and extracted as
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described above. Quantitation was carried out in MS full scan mode at resolution
70,000 only using the peak area from the extracted ion chromatograms of the
base peak ion shown in table 5.1, using a mass tolerance of 5 ppm. Calibration
curve for sulfamethoxazole was built at concentrations ranging from 0.1 ng/mL to
200 ng/mL, with R2>0.99. Method detection limit for sulfamethoxazole in
reclaimed

water

was

determined

at

67

ng/L

(n=7).

Recovery

for

sulfamethoxazole was 94 ± 14 % (n=3). Considering the structural similarity
between sulfamethoxazole and its metabolites and the availability of metabolite
standards, concentrations for acetyl-sulfamethoxazole and sulfamethoxazole
glucuronide were tentatively determined based on the response factor obtained
for sulfamethoxazole, regardless of potential matrix effects and ionization
efficiency. I was able to achieve this approximation because these compounds
were eluted fairly close to each other (within 0.22 min), thus may have suffered
similar suppression or enhancement. Moreover, the aim of this study was to
identify them and to determine the abundance of metabolites relative to their
parent drugs in environmental water samples. Therefore, retention times and
ions found in previous sections are now used for the determination of
sulfamethoxazole and its metabolites in reclaimed water samples.
5.3.5 Occurrence of Sulfamethoxazole and Its Metabolites in Reclaimed
Water
After the two phase II metabolites along with sulfamethoxazole have been
successfully identified in one of the reclaimed water extracts of routine monitoring
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for pharmaceuticals, the developed strategy was applied to screen phase II
metabolites in the reclaimed water samples collected during a period of one
month at Florida International University Biscayne Bay Campus (North Miami,
FL). Sulfamethoxazole and its two metabolites are the only group of compounds
that have been consistently detected in all the reclaimed water samples
suggesting that the waste water treatment plant is fairly effective at removing
most of the phase II metabolites. Sulfamethoxazole, on the other hand, may
represent one of the few types of pharmaceuticals whose phase II metabolites
can survive intact through sewage treatment plants. As shown in Figure 5.4,
average concentrations of sulfamethoxazole, acetyl-sulfamethoxazole and
sulfamethoxazole glucuronide were calculated at 2848 ± 1367 ng/L, 1980 ± 1410
ng/L, and 2859 ± 1526 ng/L, respectively. The two metabolites represented 54
%, on the basis of mole fraction, of the source of sulfamethoxazole in reclaimed
water. With the knowledge that sulfamethoxazole and acetyl-sulfamethoxazole
have been previously detected in wastewater, this is the first known report of
sulfamethoxazole glucuronide occurring in environmental water samples. It is
commonly believed that glucuronide conjugates are unstable during waste water
treatment as a result of being used as an energy source for microbes, the
presence of sulfamethoxazole glucuronide indicated that there might be certain
factors, such as temperature and the complex consortium of bacteria present,
that played a role in keeping the conjugates in reclaimed water. Although this is a
small sample size and may not be representative for other treatment facilities, it
is still important to be aware of that metabolites do pose a possible threat to
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surface water and drinking water sources, and ultimately to confirm the
importance of measuring pharmaceutical metabolites in the environment.
Therefore, future studies will include more commonly prescribed pharmaceuticals
and pay special attention to those undergo extensive phase II metabolism.
5.4 Conclusions
The combination of the high resolution Orbitrap mass spectrometry and
metabolic profiling software was successfully applied for the analysis of
pharmaceutical metabolites in reclaimed water. Sulfamethoxazole and its two
phase II metabolites, acetyl-sulfamethoxazole and sulfamethoxazole glucuronide,
were detected and successfully identified in reclaimed water samples using this
technique. I also illustrated that it was helpful to use characteristic ions and
MS/MS spectra to identify a compound when the standard is not available.
Preliminary results showed that the method could be easily adapted to the
analysis in various matrices such as sewage extracts, surface water and drinking
water. The resulting data can be used to evaluate the performance of reclaimed
water treatment procedures, also the fate of pharmaceuticals in wastewater
treatment plants. In the case of sulfamethoxazole, the amount of acetylsulfamethoxazole and sulfamethoxazole glucuronide needs to be considered in
order to correctly assess the fate of sulfamethoxazole as they represent the
major source of sulfamethoxazole in reclaimed water.
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Figure 5.4 Occurrence of sulfamethoxazole and its two phase II metabolites
acetyl-sulfamethoxazole and sulfamethoxazole glucuronide in reclaimed water
during a period of one month (n=7)
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CHAPTER 6
Ecological risk assessment of pharmaceuticals in reclaimed water
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6.1 Introduction
As described previously, some pharmaceuticals are not completely eliminated
because the conventional treatments used in WWTPs appear insufficient to
completely remove these specific compounds (Daughton and Ternes 1999).
Consequently, these pharmaceuticals can be released through reclaimed water
in variable quantities and reach surface waters, ground waters, and sediments
(Zuccato et al. 2000; Wang and Gardinali 2012). Although pharmaceuticals can
be degraded in the environment by biotic and/or abiotic processes and their
concentrations in environmental water bodies are typically at ng/L to low µg/L
level, these organic pollutants may still pose risks to aquatic species under
chronic long-term exposure (Sanderson et al. 2003; Gunnarsson et al. 2008;
Pounds et al. 2008; Quinn et al. 2009; Berninger and Brooks 2010). Since many
aquatic species were shown to have similar physiological receptors to those the
pharmaceuticals are originally intended to react with in humans (Gunnarsson et
al. 2008; Berninger and Brooks 2010), the probability of ecological risks that
these compounds pose to aquatic organisms cannot be ruled out.
Ecological risk assessment (ERA) is the process of analyzing and evaluating the
probability of adverse ecological effects caused by environmental pollutants
(USEPA 1998). In recently years, probabilistic approach which determines the
probability of an exposure concentration exceeding the probability of effects has
been increasingly used in ERA procedures (Solomon et al. 2001; Carriger and
Rand 2008). This is because, when used correctly, it can introduce greater
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statistical confidence into risk assessment when compared to traditional hazard
quotient and assessment factor approaches (Wheeler et al. 2002). However,
problems associated with assessing risk of pharmaceuticals include the very
large number of pharmaceuticals in use today and the availability of good toxicity
benchmarks. In addition, many pharmaceuticals are biologically degraded to
active metabolites that have not been fully evaluated. Therefore, on the basis of
previous results (Chapter 4), five bioaccumulative pharmaceuticals including
caffeine, carbamazepine, diltiazem, diphenhydramine, and ibuprofen detected in
the worst case multiple exposure of reclaimed water will be fully investigated
regarding acute and chronic risks to aquatic organisms.
The objective of this chapter is to assess the probabilistic risks associated with
the pharmaceuticals in reclaimed water used for daily irrigation at Florida
International University Biscayne Bay Campus. The procedures include risk
analysis and risk characterization by comparing distributions of exposure
concentrations of these pharmaceuticals with species sensitivity distribution data
from well described laboratory toxicity studies.
6.2 Methods
6.2.1 Exposure and toxicity data
Concentrations of the five bioaccumulative pharmaceuticals in reclaimed water
were obtained from Chapter 4 (Table 4.2), and charted in Figure 6.1. Measured
concentrations were ranked from the smallest to the highest to assign a centile
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ranking (j) using equation j × 100 / (n+1), where j is the rank and n is the total
number of observations (Hall et al. 2009).
Acute (LC50/EC50) and chronic (NOEC) laboratory toxicity data for water
exposure were collected from USEPA AQUIRE database and literatures (PinaVaz et al. 2000; Kim et al. 2007; Moore et al. 2008; Pounds et al. 2008; Kim et al.
2009; Quinn et al. 2009; Berninger et al. 2011; Li et al. 2011), and used to
develop species sensitivity distributions (SSDs) for each pharmaceutical. For a
distribution to be considered for analysis, at least four suitable species end points
were used to construct SSDs (Wheeler et al. 2002; Carriger and Rand 2008).
Only toxicity data characterized by a specified end point that could be clearly
related to changes in population structure such as growth, reproduction and
survival were used in the SSDs. Where data from multiple studies on the same
species were available, the geometric mean toxicity values were used to
represent the species in the distribution (Carriger and Rand 2008). End point
values greater than water solubility were excluded. Chronic toxicity data for
diltiazem were limited and the SSD could not be developed.
All toxicity data used for SSDs were assumed to fit a log-logistic distribution and
graphical

output

was

produced

by

an

EPA

SSD

generator

(http://www.epa.gov/caddis/downloads/SSD_Generator_V1.xlt). Log-transformed
end point concentrations were plotted against the cumulative probabilities for
each species. The 10th centile for each SSD was determined and chosen as the
primary benchmark or threshold for effects on communities of aquatic species
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(Wheeler et al. 2002), however, the 5th centile values were also calculated for
comparison purposes.
6.2.2 Risk assessment
Risk was assessed by comparing the overlap of the distributions of exposure
concentrations and the SSDs. The estimated 90th centile of exposure
concentrations were compared to the estimated 10th and 5th centile
concentrations from the acute SSDs (Solomon et al. 2001). The 90th centile
represents a concentration that would only be expected to occur 10% of the time
and would represent episodic or pulsed exposures (Rand et al. 2010). The
estimated 50th centile exposure concentrations were compared to the estimated
10th and 5th centile concentrations of the chronic SSDs (Solomon et al. 2001).
The 50th centile concentration was chosen as a comparison to chronic SSDs on
the basis of that it might be more representative of background concentrations as
50% of the exposures are anticipated to be above or below this level at a site
(Rand et al. 2010).
When a centile from exposure distribution data was applied to SSD, the
potentially affected fraction (PAF) of species was calculated (Van Beelen et al.
2001; van de Meent and Huijbregts 2005). Any exceedences above the 10th
centile of a SSD were noted for acute and chronic risk. The PAF is important to
understand the fraction of species that is expected to be potentially affected
above its acute or chronic benchmark at a given environmental concentration.
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The calculation for PAF is shown in the following equation (Carriger and Rand
2008).

where α is the mean of log toxicity data, β is equal to σ × 3 /π while σ is the
standard deviation and x is the log of the exposure concentration. As described
above, x was determined to be the 90th and 50th centiles of the exposure
distribution for acute and chronic effects, respectively.
Next, joint probability curves (JPCs) were constructed for the pharmaceuticals
that showed the highest PAF values. Joint probability curve is a function of
probability of exposure and magnitude of ecological effects and used to
determine the proportion of toxicity values from the SSD that are exceeded by
ranges of exposure concentrations (Carriger and Rand 2008). For instance, a
JPC for pharmaceutical A shows that there is a 5% probability that the exposure
of A will affect 10% of the species in SSD, but another JPC for pharmaceutical B
may present 15% probability that the exposure of B will affect the same
proportion of species in SSD. One can conclude that pharmaceutical B may pose
higher risk than pharmaceutical A to aquatic species and is therefore of greater
concern. Therefore, JPC provides a means of comparing relative potential risk
when toxicity and exposure data are sufficiently robust.
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6.3 Results and discussions
Exposure concentrations of the selected pharmaceuticals in reclaimed water are
shown in Figure 6.1 as boxplot. The bar closest to zero indicates the 10th centile,
a line within the box marks the median (50th centile), and the bar farthest from
zero indicates the 90th centile. The 50th and 90th centiles of the exposure
concentrations were determined and presented in Table 6.1. The highest 90th
and 50th centile concentrations occurred for caffeine at 9.66 µg/L and 8.39 µg/L,
respectively. The lowest 90th and 50th centile concentrations occurred for
diltiazem at 0.183 µg/L and 0.159 µg/L, respectively.

Figure 6.1 Boxplot of exposure concentrations (n=7) of selected pharmaceuticals
in reclaimed water
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The acute and chronic SSDs for the selected pharmaceuticals are shown in
Figure 6.2 and Figure 6.3, respectively. A summary of the acute and chronic
toxicity data including the 5th and 10th centiles from respective SSDs is
presented in Table 6.2. Chronic SSD for diltiazem was not constructed as a
result of limited chronic toxicity data. All centile concentrations from both acute
and chronic toxicity data were at least one order of magnitude higher than the
exposure concentrations, except for the chronic 5th and 10th centile
concentrations of carbamazepine. The results indicate that carbamazepine may
pose higher risk than other pharmaceuticals as it is the only compound that
shows overlap between the exposure concentrations and the toxicity data.
However, further probabilistic assessment is needed to confirm the risk and the
results will be discussed later.
Table 6.1 90th and 50th centiles of exposure
concentrations
90th centile of
exposure
concentration (µg/L)

50th centile of
exposure
concentration (µg/L)

caffeine

9.66

8.39

carbamazepine

1.37

1.18

diltiazem

0.183

0.159

diphenhydramine

6.72

5.53

ibuprofen

0.359

0.347
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All the chronic toxicity data were lower than the acute toxicity data indicating that
the aquatic organisms under chronic exposure of these pharmaceuticals are
more likely to be affected than under the acute exposures. The chronic and acute
SSD centile concentrations were relatively close (within one order of magnitude)
for caffeine and diphenhydramine. Carbamazepine and ibuprofen, on the other
hand, had much lower chronic toxicity centile concentrations than their acute
values (Table 6.2), suggesting that chronic exposure of carbamazepine or
ibuprofen may pose higher risks than acute exposure.
Table 6.2 The 5th and 10th centiles of toxicity data from acute and
chronic SSDs
Acute SSD

Chronic SSD

5th
centile
(µg/L)

10th centile
(µg/L)

5th
centile
(µg/L)

10th centile
(µg/L)

caffeine

16039

26070

4465

7442

carbamazepine

2253

3730

3.90

14.2

diltiazem

2479

4041

N/A

N/A

diphenhydramine

438

598

139

336

ibuprofen

3977

5992

64

160

N/A indicates that data were not available for the compound.
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Figure 6.2 Acute species sensitivity distributions with 95% Confidence Interval for
caffeine, carbamazepine, diltiazem, diphenhydramine and ibuprofen
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Figure 6.3 Chronic species sensitivity distributions with 95% Confidence Interval
for caffeine, carbamazepine, diphenhydramine and ibuprofen

Potentially affected fractions were calculated and shown in Table 6.3. The
potentially affected fraction values for caffeine, diltiazem and ibuprofen were
zero. The results indicate that there was no overlap between the exposure
concentration and the SSD for each pharmaceutical. Acute and chronic PAFs for
diphenhydramine were calculated at 0.1% and 0.3%, respectively. Chronic PAF
for carbamazepine was calculated at 2.4%, but the values (less than 3%) were
generally considered low (Carriger and Rand 2008; Xing 2012).
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Table 6.3 Statistics and potentially affected fraction (PAF) for acute and
chronic toxicity data for pharmaceuticals

caffeine
carbamazepine
diltiazem
diphenhydramine
ibuprofen

x

α

σ

β

PAF %

Acute

0.985

4.339

0.616

0.340

0.0

Chronic

0.924

4.654

0.535

0.295

0.0

Acute

0.137

4.307

0.522

0.288

0.0

Chronic

0.071

3.128

1.493

0.823

2.4

Acute

-0.737

4.355

0.564

0.311

0.0

Chronic

-0.799

N/A

N/A

N/A

N/A

Acute

0.828

3.041

0.557

0.307

0.1

Chronic

0.743

3.876

0.990

0.546

0.3

Acute

-0.445

4.406

0.474

0.262

0.0

0.467

0.0

Chronic
-0.460
3.468
0.847
N/A indicates that data were not available for the compound.

Zero indicates that there was no overlap between the exposure concentration
and the SSD.

On the basis of chronic PAF values, carbamazepine could be considered as a
compound of concern. Therefore, a JPC was developed and shown in Figure 6.4.
It can be seen that the curve was extremely close to the axes. As a matter of
fact, the probability for 5% of species affected was zero, indicating a very small
probability of adverse effects.
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Figure 6.4 Joint probability curve for the exposure concentration and chronic
toxicity data of carbamazepine
6.4 Conclusion
In this chapter, five bioaccumulative pharmaceuticals including caffeine,
carbamazepine, diltiazem, diphenhydramine and ibuprofen detected in reclaimed
water were investigated to assess the potential acute and chronic risks to aquatic
organisms. The results showed that aquatic organisms under chronic exposure
of these pharmaceuticals are more likely to be affected than under acute
exposure. In addition, the joint probability curve for the exposure and chronic
toxicity data of carbamazepine indicated a quantifiably low potential risk even
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under the worst case exposure to reclaimed water. Given the dilution factors that
affect environmental releases, the risk of exposure to carbamazepine will be
even more decreased.
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CONCLUSIONS
The overall objectives of this research were to develop analytical methods for the
determination of trace level pharmaceuticals and metabolites as emerging
environmental contaminants using the-state-of-art mass spectrometry in different
matrices, and to gain knowledge about the occurrence, distribution and variance
of these pharmaceutically active compounds in the South Florida environment as
well as the information regarding bioconcentration factors and pharmacokinetics
in aquatic species being affected by wastewater under various exposure
scenarios.
As a result, two protocols were successfully developed for targeted analysis and
unknown phase II metabolites screening. A specific and sensitive triple quadruple
mass spectrometer was used in the targeted analysis of pharmaceuticals in
mosquito fish and surface water directly affected by reclaimed water. A high
resolution Orbitrap mass spectrometer was used in the phase II metabolites
screening.
After a comprehensive evaluation of a large number of environmental samples, it
was confirmed that a number of pharmaceuticals at concentrations that could
range up to μg/L were routinely introduced into the environment from a typical
secondary

wastewater

treatment

plant.

Compounds

such

as

caffeine,

diphenhydramine and carbamazepine were consistently detected in reclaimed
water and surface water from a fresh water pond directly affected by reclaimed
water.

Bioaccumulation

factors

for
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caffeine,

diphenhydramine

and

carbamazepine in mosquito fish living in this pond were also calculated and
found at 29 ± 26, 821 ± 422 and 108 ± 144, respectively.
In order to understand the uptake and depuration as well as bioconcentration
factors (BCFs) under the worst-case conditions, mosquito fish were exposed to
reclaimed water under static-renewal for 7 days, followed by a 14-day depuration
phase in clean water. The results showed that some pharmaceuticals such as
diphenhydramine could be accumulated in fish up to 82 ng/g while some
pharmaceuticals such as caffeine will rather equilibrate with the surrounding
waters and would persist for a period of several days. The study also showed
that a number of other compounds detected in rather high concentrations (e.g.
diclofenac and gemfibrozil) did not accumulate in fish despite having moderately
high Log Kow values implying that other mechanisms may have played a role in
keeping them in solution. Because many aquatic species have similar
physiological receptors to those originally targeted for pharmacological effects in
humans, non-target species under chronic exposure may show potential adverse
effects.
Next, the combination of the power of high resolution Orbitrap mass spectrometry
and metabolic profiling software was successfully applied for the analysis of
pharmaceutical metabolites in reclaimed water. Sulfamethoxazole and its two
phase II metabolites, acetyl-sulfamethoxazole and sulfamethoxazole glucuronide,
were successfully identified in reclaimed water using this technique. It was also
illustrated that it was helpful to use characteristic ions and MS/MS spectra to
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identify a compound when the standard is not available. Preliminary results
showed that the method could be easily adapted to the analysis in various
matrices such as sewage extracts, surface water and drinking water. The
resulting data can be used to evaluate the performance of reclaimed water
treatment procedures, also the fate of pharmaceuticals in wastewater treatment
plants. In the case of sulfamethoxazole, the amount of acetyl-sulfamethoxazole
and sulfamethoxazole glucuronide needs to be considered in order to correctly
assess the fate of sulfamethoxazole as they represent the major source of
sulfamethoxazole in the reclaimed water.
Finally, five bioaccumulative pharmaceuticals including caffeine, carbamazepine,
diltiazem, diphenhydramine and ibuprofen detected in reclaimed water were
investigated regarding the acute and chronic risks to aquatic organisms. The
results showed that aquatic organisms under chronic exposure of carbamazepine
are more likely to be affected than the exposures of any other selected
pharmaceuticals. In addition, the joint probability curve for the exposure and
chronic toxicity data of carbamazepine indicated a low potential risk of
carbamazepine even under the worst case exposure scenario. However, given
the dilution factors that affect environmental releases, the risk of exposure to
carbamazepine will be drastically decreased.
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